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Abstract
Alternative splicing is an important post-transcriptional process that serves to in-
crease the diversity of proteins in different tissues and developmental stages, and its
dysregulation is often associated with diseases. Large-scale RNA-seq experiments
and bioinformatic approaches already found evidence of splice site selections and
interaction among cis-regulatory elements and trans-acting factors. However, in most
cases, the mechanisms behind are still incompletely understood and remain to be
determined. Therefore, there is a great need to accurately map and quantify gene
splice variants, identify differences in splicing between conditions and computationally
reveal the splicing regulation. In this dissertation, we investigate those challenges and
propose novel computational methods to mitigate them. I will highlight my Ph.D.
works on alternative splicing and present machine learning and statistical methods to
extract gene and alternative splicing features from large collections of RNA-seq data,
determining statistically significant differences in expression and splicing measurements
between conditions, and predicting the splicing regulations of cis-regulatory sequence
elements and trans-acting factors.
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In this thesis, we focus on the pre-messenger RNA (pre-mRNA) splicing process, and
design computational methods to predict and reveal the splicing regulatory code.
To start, I will introduce the biological background, namely what is pre-mRNA
splicing, why alternative splicing is important, what is the machinery that regulates
splicing events, and where the gene data come from.
1.1 Biological background
Three major kinds of molecules are important for most of the living organisms,
namely deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and protein. DNA is a
long double-stranded molecule that contains the genetic code for the development,
functioning, growth and reproduction of all known organisms. A set of special sequences
in the DNA, called genes, carry the genetic instructions needed for making the proteins.
Protein, on the other hand, is an essential functional part of organisms. Proteins are
made of amino acids, function as a cell’s "building blocks", and participate in virtually
every process within cells. In between, RNA acts as a carrier that translates genetic
information that is encoded in the DNA into protein.
According to the central dogma, DNA contains the information needed to make all
of the proteins (Figure 1-1). RNA is "transcribed" from DNA, acting as a messenger
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that carries the information encoded in DNA to the ribosomes. The ribosomes serve as
factories in the cell where the information is "translated" from a code into the functional
product - proteins. This process by which the DNA instructions are converted into
the functional product is called gene expression.
Figure 1-1. The central dogma.
Gene expression involves two key stages, transcription and translation. In tran-
scription, the information in the DNA of every cell is converted into small, portable
RNA messages. During translation, these messages travel from where the DNA is in
the cell nucleus to the cytoplasm where ribosomes direct protein synthesis.
1.1.1 RNA transcription and RNA splicing
In humans and other eukaryotes, transcription of eukaryotic organisms contains two
main stages. In the first stage, an RNA sequence is formed by reverse complementing
the original DNA sequence. When an enzyme called RNA polymerase binds to a DNA
strand of a gene in a region called the promoter, the RNA polymerase reads the DNA
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strand and builds the pre-mRNA molecule, using complementary base pairs. This
process continues until the RNA polymerase crosses a stop (termination) sequence in
the gene. This newly generated RNA is called pre-messenger RNA (pre-mRNA) and
it is not quite ready to go. Pre-mRNA has to go through several processing steps to
become a mature messenger RNA (mRNA) that can be translated into a protein.
These include the addition of a 5’ cap and a 3’ poly-A tail molecules to the two
ends of the transcript to prevent degradation by the enzymes, and an excision process
of removing non-coding sequences (called introns) and joining together the coding
sequences (called exons) to form the mRNA.
The excision process is called the RNA splicing. The RNA splicing reactions are
carried out by the spliceosome — a dynamic RNA–protein complex with a highly
regulated functional cycle found in all eukaryotes [1]. There are two kinds of splicing
events. Constitutive splicing events are recognized efficiently by the spliceosome
and are spliced the same way in each pre-mRNA from a given gene. In contrast, in
alternative splicing events, recognition and joining of a 5’ and 3’ splice site pair are in
competition with at least one other 5’ or 3’ splice site.
1.1.2 Splicing, spliceosome, and RNA binding proteins
Splicing is the RNA regulatory process that we are mainly interested in, therefore it
is necessary to describe this process in more detail. A splicing event can be described
as the excision of the non-coding sequences (introns) from a pre-mRNA and joining
of the coding sequences (exons). The special sequences at the intron/exon junctions
are called the splice sites. Typically, the splice sites include a GU dinucleotide at the
intron 5’ end (5’ splice site), a terminal AG at the 3’ end (3’ splice site) and a branch
point (with an A) close to the 3’ splice site [2] (Figure 1-2).
The splicing process involves a series of biochemical reactions that are catalyzed
by the spliceosome, a large molecular complex composed of four small nuclear ribonu-
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cleoproteins (U1, U2, U4/U6 and U5 snRNPs) and approximately 50–100 non-snRNP
splicing factors [3]. The spliceosome assembles onto each intron, with the binding of
the U1 and U2 snRNP to the splice sites and the assistance of the splicing factors
(e.g. SF1, U2AF65, U2AF35) to help locate the binding sites (Figure 1-3).
Figure 1-2. Illustration of pre-mRNA
splicing (image from [4]).
Figure 1-3. Illustration of spliceosome
assembly (image from [4]).
1.1.3 Alternative splicing
Because of the alternative splicing events, the pre-messenger RNA is not always the
same. A pre-messenger RNA segment may be spliced out or included in different
ways (Figure 1-4), giving rise to several different possible mRNA products, potentially
coding for different protein isoforms [4]. These protein isoforms differ in their peptide
sequence and hence have different biochemical properties and biological functions.
Alternative splicing is a major contributor to both protein diversity and genetic
regulation in higher eukaryotes. It is important in many cellular and developmental
processes, including sex determination, apoptosis, axon guidance, cell excitation and
contraction, and many others [5–7]. Estimates are that more than 90% of human
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genes undergo alternative splicing [8]. Moreover, many genes have multiple splicing
patterns, and some have thousands [9, 10]. Splicing is tightly regulated in different
tissues and developmental stages, and the mis-regulation of splicing is often involved
in human diseases [11–13], with an estimate that as many as 50% of disease causing
mutations affect splicing [14–16].
Figure 1-4. Illustration of alternative splicing.
1.1.4 Next generation sequencing
To understand splicing regulation and other gene processes, the sequencing reads
from the next generation sequencing (NGS) platform are typically used. NGS is a
technology for determining the sequence of DNA or RNA molecules to study genetic
variation associated with diseases or other biological phenomena. With its ultra-high
throughput, scalability, and accuracy, NGS has revolutionized genomics analyses and
enabled new applications in genomic and clinical research, reproductive health, and
many other areas.
Reads are pieces of sequencing fragments of DNA or RNA generated by NGS
platforms. Bioinformatics analysis tools typically map the individual reads to the
human reference genome to detect related genes (or features), alternatively spliced
transcripts, allelic gene variants and single nucleotide polymorphisms.
Detection of splicing variations and mapping of the complex transcriptome have
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been greatly facilitated by the development of the NGS high-throughput RNA sequenc-
ing (RNA-seq) technology, which enables quantitative profiling of the transcriptome in
a wide variety of cell types and conditions. Briefly, millions of RNA sequencing reads
are generated from the gene features, thus providing an effective means to determine
the set of genes and splice isoforms. For the purposes of evaluating differences in
splicing patterns and expression levels of genes between conditions, RNA-seq read
counts are summarized at the genomic level of interest, such as introns, exons or full
isoforms. In particular, introns reflect both the structure and abundance of genes and
their isoforms, and are the gene features to most accurately detect from sequencing
data, and therefore can be used more reliably to detect alternative splicing variation.
However, accurately quantifying intron abundance, determining the full extent of
splicing variation, and comparing gene splicing profiles among biological states remains
challenging.
1.2 Outline
My work entails developing statistical and machine learning models and tools for
characterizing the cellular transcriptome and its variations along RNA processing
pathways, in particular as it relates to primary RNA splicing, using large scale genomics
data. In particular, we developed several methods under the umbrella of the JULiP
project (JULiP, JULiP2 and MntJULiP) to determine and characterize alternative
splicing variation of genes as represented by splice junctions (introns), and to compare
them between experimental conditions in large-scale RNA-seq experiments. Second,
we developed a deep learning model of sequences and alignments for the bioinformatics
problem of predicting alternative splicing from the local genomic sequence context.
In this thesis, I will describe the primary projects that I worked on during my
Ph.D. study; the remaining chapters are organized as follows.
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1.2.1 JULiP and JULiP2
In Chapter 2, I will discuss the JULiP and JULiP2 methods for selecting, quantifying
and comparing intron sets from large collections of RNA-seq data. JULiP and JULiP2
are based on the Generalized Linear Model (GLM), and leverage the latent gene
information across all of the analysis samples. JULiP predicts an accurate set of
introns from a large RNA-seq sample databases and JULiP2 uses the predicted introns
to determine differential splicing of genes.
1.2.2 MntJULiP and Jutils
In Chapter 3, I will present MntJULiP and Jutils. MntJULiP is a differential splicing
analysis tool that implements novel Dirichlet-multinomial and zero-inflated negative
binomial models within a Bayesian framework to detect both changes in splicing ratios
and in absolute splicing levels of introns with high accuracy, and can find classes of
splicing variation overlooked by reference tools. Additionally, a mixture model allows
multiple conditions to be compared simultaneously. MntJULiP is highly scalable, and
can process hundreds of GTEx samples in <1 hour to reveal splicing constituents of
phenotypic differentiation.
To visualize the results of MntJULiP and other popular differential splicing pro-
grams, we developed the toolkit Jutils. Jutils extracts the program predictions into a
unified format file for visualization. Jutils can visualize alternative splicing events in
several ways, including heatmaps, Venn diagrams and sashimi plots.
1.2.3 A Deep Learning (DL) splicing model
In Chapter 4, I will introduce a deep learning (DL) based model of alternative splicing,
trained to predict splicing ratios of given splice junctions (introns). The previously
described MntJULiP program receives as input the RNA-seq reads directly, from
which it extracts the read counts and predicts the splicing ratio. In contrast, the
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DL model receives as input the motif information of known RNA binding proteins
(RBPs) as position weight matrices (PWMs) along with the RNA sequences around
the alternative splice junctions. The network then learns the latent information on
trans-factors (RBPs), cis-elements (motifs), and how they work together to regulate




A typical RNA-seq data analysis aims to analyze the transcriptome in a given RNA-seq
sample, condition, or experiment. In more specific terms, it aims to determine the
expressed genes and transcripts, their expression levels and, in a multi-condition
experiment, differences in expression levels and splicing patterns that could lead to
reproducible markers. The RNA-seq data analysis component starts with the millions
of short reads generated from a given RNA sample. Reads are mapped to a reference
genome and to the genomic feature of interest (e.g., gene, transcript, exon or intron),
and the normalized and/or estimated read counts are used to measure the abundance
of the feature in the analyzed samples. A critical problem in the analysis work is
determining a reliable set of features that can be used as the basis for measuring
expression and splicing levels. Accurate detection of such features is hampered by
sequencing and alignment artifacts. Further, once a reference ‘database’ of features
has been established, determining biologically significant differences in expression and
splicing levels of features, using rigorous statistical methods that take into account
information from multiple biological replicates, is critical for identifying a set of
informative and reproducible markers.
Our first major research interest in this area, therefore, involves developing machine
learning and statistical methods to extract gene and alternative splicing features (herein,
introns) from large collections of RNA-seq data and refine them into high-confidence
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reference sets. Our second major interest is in determining statistically significant
differences in expression and splicing measurements between conditions.
In the following section, we present background information and previous work.
We then describe our tools JULiP, for accurate intron selection from multiple RNA-seq
samples, and JULiP2, which extends JULiP’s statistical model and incorporates
differential splicing prediction.
2.1 Background
2.1.1 Accurate prediction of alternatively spliced features
By far the most efficient means for detecting splice variation large scale is by com-
putational prediction. When a reference genome is available, transcript assembly
programs (e.g., Cufflinks [17], CLASS2 [18], StringTie [19], FlipFlop [20] and others
reviewed in [21]) can be used to assemble RNA-seq reads aligned to the genome
into gene and transcript models. These methods create a graph representation of
a gene and its possible alternative splicing combinations, from which a subset of
transcripts is selected using linear or quadratic programs, dynamic programming,
and network flow optimization [21]. Local splice variation can then be extracted
from these annotations. The assembly process, however, is difficult and fraught with
errors [18, 22]. As an alternative, introns represent the building blocks of full-length
isoforms as well as of local alternative splicing events, such as exon skipping, mutually
exclusive exons, and alternative exon and gene ends, and have been used to detect and
characterize alternative splicing variation in practice [23, 24]. Therefore, accurate and
comprehensive identification of the set of expressed introns in a given set of RNA-seq
samples is critical for all gene and splice variation analyses downstream.
Current assembly-based methods depend critically on the quality of the reference
genome, precision of the read mapping software, and depth of coverage with RNA-
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seq reads. False positives can result from spurious RNA fragments during library
preparation, incorrect alignment, and intronic and intergenic ‘noise’ from unspliced
RNA. False negatives can arise from low expression genes, which typically have only a
handful of reads and are partially reconstructed. Therefore, analyzing each sample
individually limits both the accuracy and the potential to identify splice variants, in
particular rare or low expression events.
Batch sequencing of large numbers of RNA-seq samples from multiple replicates,
tissues or populations is becoming increasingly common [25–27]. Current approaches
that process one data set at a time are not capable of seamlessly and efficiently analyzing
such massive collections. Designing tools that can simultaneously analyze multiple
samples, however, is challenging due to the large number of artifacts compounded
over the full collection of data sets and also to the sheer volume of data. So far only a
handful of algorithms have been proposed to assemble reads across multiple sample:
CLIIQ [28], an early prototype algorithm that uses an integer linear programming
(ILP) approach with variables the full set of isoforms; MiTie [29], which builds a
splicing graph representing the gene and maximizes a likelihood function using mixed
integer programming with a regularization penalty; and ISP [30], which solves an
LP or ILP problem iteratively on a weighted connectivity graph derived from the
input samples. While marking significant conceptual advances, they scale poorly
(MiTie) or otherwise have limited performance in detecting splicing variation (ISP).
Therefore, a highly efficient and accurate feature selection algorithm is needed. Our
JULiP algorithm selects a highly accurate subset of introns from a large collection
of RNA-seq data directly from alignments, using latent gene information across the
samples incorporated into generalized linear models.
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2.1.2 Detection of differentially spliced features
Gene alternative splicing plays an important role in development, tissue specialization
and disease, and differences in splicing patterns can reveal important factors for
phenotypic differentiation. Aberrant alternative splicing has been associated with
a wide spectrum of diseases, including cancers [31]. The importance of alternative
splicing emphasizes the need to accurately map and quantify splice variations, and to
detect differences in splicing patterns between cellular conditions.
There are three classes of methods for differential splicing detection, based on the
splicing feature of interest (Figure 2-1). The first class is that of isoform based methods,
such as the assembly-based Cufflinks/Cuffdiff pipeline [17, 32]. The Cufflinks/Cuffdiff
pipeline constructs a set of isoforms, quantifies the expression that best explains
the observed reads, and determines differential splicing in two ways. First, Cuffdiff
measures differences in isoform expression between conditions, to determine instances
of isoform-level regulation. Second, it determines differences in the relative usage of
isoforms within a gene, using the Jensen–Shannon divergence to measure and compare
the similarity between two probability distributions.
Figure 2-1. Methods may detect differential splicing at the isoform, alternative splicing
event, and exon/intron level.
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The second class of methods focuses on specific types of alternative splicing events
which have been categorized into several common types, including exon skipping,
mutually exclusive exons, intron retention and alternative 3’/5’ splice sites. Alternative
splicing events can be detected from RNA-seq reads mapped to exons or exon junctions,
either starting from a reference set of gene annotations or by building a gene schematic
representation such as a splice graph, annotated with the number of observed reads
that unambiguously support the presence or absence of each splicing event. Comparing
the read counts between mutually exclusive paths (isoforms) gives an estimate of the
relative contribution of each isoform, which can then be compared between conditions.
As an example, the software rMATS [33] retrieves candidate alternative splicing
events from an input annotation, extending the set with introns from the input
alignments. It then uses the counts of reads mapped to the two mutually exclusive
isoforms, for instance exon inclusion or exon skipping in the case of an exon skipping
event, in a bayesian framework to estimate a value called the percent splicing inclusion
levels (ψ), and determine statistically significant differential events.
Another tool, MAJIQ [34], quantifies RNA splicing in units of local splicing
variations (LSV). LSVs are defined in the splice graph where several edges share either
the start or the end endpoint of a same exon. MAJIQ models LSVs as structural
network motifs and estimates an a posterior marginal distribution over the fractions
on LSVs, defined by the percent selected index (PSI), and further determines changes
in PSI between two conditions (dPSI).
Further, DiffSplice [35] defines so called Alternative Spliced Modules (ASM) in
splice graphs. An ASM is a region in a splice graph where isoforms differ from each
other, hence each ASM has at least two alternative paths. ASM seeks to minimize
the ambiguity in isoform resolution by only considering regions that are not shared
by all isoforms. DiffSplice tests for differential splicing of each ASM instead of whole
transcripts. The relative abundances of alternative paths are estimated using the
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maximum likelihood method. As with Cuffdiff, the difference of the relative abundance
composition is measured using the Jensen-Shannon divergence metric (JSD) at the
level of ASMs.
The third type of methods do not directly quantify the expression levels of tran-
scripts or AS events, rather they use differential exon/intron usage as a surrogate to
infer differential isoform usage. These methods divide a gene into typically disjoint
counting bins, and the number of observed reads overlapping each bin is counted.
Bins can be full or truncated exonic regions, junction regions, or both. To infer
differential exon/intron (bin) usage between conditions, these methods often make use
of (generalized) linear models with the assumption of Poisson or negative binomial
distributions on read mappings. The models contain an interaction term between the
bin identifiers and the condition of interest to search for non-proportionality of the
bin counts within a gene between the conditions.
One such method, DEXSeq [36], collects reads by bins of exons or subexons, and
uses a generalized linear model to detect the differential usage of counting units across
conditions. Similar to DEXSeq, JunctionSeq [37] constructs bins for read counts
on individual exons and/or splice junctions from the counts of the whole gene. In
contrast, LeafCutter [38] clusters introns that share a donor or an acceptor splice
site. Introns are represented by splice junction read counts and jointly modeled by a
Dirichlet-multinomial generalized linear model.
In the following sections, we present our tools JULiP and JULiP2, two new
statistical models to select introns and to determine differential alternative splicing
events at the intron-level from two-group RNA-seq data with replicates. As a brief
introduction, JULiP and JULiP2 work in multiple steps (Figure 2-2)
• receive as input RNA-seq read alignments (the BAM file) and construct the set
of candidate introns and their splice junction read counts;
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• use the gene regions extracted from a reference genome annotation to group the
introns and their read counts;
• for each gene region intron group, estimate intron abundance using the regularized
program and select an optimal set of introns;
• in addition, for the differential analysis task in JULiP2, estimate the differential
usage of introns by a generalized linear model (GLM) coupled with a Wald test.
Figure 2-2. The architecture of JULiP and JULiP2
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2.2 JULiP: An efficient model for accurate intron
selection from multiple RNA-seq samples
Determining a high confidence and complete set of features is critical for the accuracy of
downstream differential and functional analyses. Our tool JULiP (JUnction prediction
using an L1-regularized Program) implements a L1-regularized model to identify and
select a highly accurate set of introns from large scale RNA-seq data sets [39]. Unlike
traditional approaches that extract introns from each sample and then merge them
per sample sets, our model selects introns directly by criss-crossing information across
all input samples. Specifically, for each gene region, JULiP solves an L1-regularized
program iteratively on the aggregate set of introns extracted from the multi-sample
RNA-seq data set. When evaluated on simulated and real data, JULiP detected introns
with both very high precision (>98%) and high sensitivity (>89%). In particular, it
detected at least 30% more introns in each sample compared to traditional assembly-
based approaches, and 10% more than the cumulative intron set of all samples, at
higher or comparable precision [39].
We next introduce the mathematical model and provide details of the algorithm and
implementation. We then compare JULiP with existing approaches on both simulated
and real RNA-seq data sets, and discuss scalability and practical implications.
2.2.1 Methods and implementation
2.2.1.1 The core optimization formulation
We assume that reads from RNA-seq samples are generated independently and follow
a Poisson distribution. Given a gene region, we denote V the candidate set of introns,
and S the sample set. We define a set of observations X = {xsv | v ∈ V, s ∈ S}, where
xsv is a random variable representing the number of reads aligned to intron v in sample
s. Each variable xsv follows a Poisson distribution with mean λsv, which is the expected
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count of intron v in sample s. More specifically:
λsv = N sβv, (2.1)
where N s is the total number of mapped reads in sample s and βv is a coefficient
that describes the abundance ratio of intron v in transcripts of the gene, which needs
to be estimated. We assume samples are derived from the same cell type or condition,
and therefore intron utilization is similar across all samples. Thereby, the likelihood
function is:


















Taking the logarithm of the above equation, we have:





(λsv − xsvlnλsv + ln(xsv!)) (2.3)







(λsv − xsvlnλsv) (2.4)
The total number of candidate introns collected from all samples is large, but only
a limited number of introns are expected to be real. Therefore, the solution must be







(λsv − xsvlnλsv) + t∥β∥1 (2.5)
where t > 0 is the regularization parameter, and β = [β1, β2, ..., β|V |].






To summarize, the optimization problem can be expressed as:
arg minβ J(β; t)
s.t. t > 0,
βv ≥ 0,
λsv = N sβv
(2.7)
2.2.1.2 Implementation
JULiP works in three steps (Figure 2-3):
(1) construct the set of candidate introns and their read counts;
(2) assign reads from multiple samples into gene regions (as bins); and
(3) estimate intron abundance using the regularized program and select an optimal
set of introns.
Figure 2-3. Overview of JULiP implementation.
In step 1, JULiP aligns all reads to the genome, separately for each sample, using
the spliced alignment program TopHat2 [40]. A set of candidate introns and their
read counts in each sample are then inferred from the spliced alignments. To reduce
ambiguity due to reads mapping to multiple locations, we use the counts of uniquely
mapped reads.
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In step 2, overlapping read alignments in each sample are merged to form contiguous
exonic regions, which are then connected via the introns from step 1 into larger gene
regions. Regions from individual samples are further merged across all samples and
used as ‘bins’ for clustering introns. This process may create long regions possibly
containing several genes. Large ‘bins’ harboring hundreds of introns can significantly
affect performance as well as the accuracy of the program, for instance when genes
with varying expression levels are being clustered together. Therefore, before intron
selection JULiP splits a region if the sequence of intron counts changes abruptly over
a fixed window.
Lastly, step 3 selects a subset of candidate introns believed to be expressed in
the samples and estimates their abundance levels, using the L1-regularized program
from the previous section. The algorithm iteratively estimates the abundance ratio
β of introns based on their read counts. The process updates β and reduces the
regularization parameter t simultaneously, and is iterated until convergence.
To further speed up the program for application to very large RNA-seq collections,
we also implemented our model using the Hadoop distributed framework. With this
implementation, JULiP can solve individual programming problems from hundreds and
potentially thousands of samples simultaneously across tens or hundreds of computers.
2.2.2 Evaluation
An accurate set of introns is critical for building complete transcript models and for
identifying alternative splicing variation. We evaluated JULiP and several transcript
assembly methods including Cufflinks (v2.2.1) [32], CLASS2 (v2.1.2) [18], StringTie
(v1.2.2) [19] and FlipFlop (v1.9.6) [20], as well as the multi-sample assembler ISP
(v0.3) [30] on both simulated and real RNA-seq data. (MiTie [29] was prohibitively
slow, requiring more than a week to process a single gene region, and was unable to
handle long gene regions, and therefore was omitted.)
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For the single-sample programs, we assemble transcripts for individual samples,
then extract and aggregate introns from all samples. We ran each program with the
default settings and, where applicable, in ‘sensitive’ mode (denoted ‘_F001’), where
we adjusted the minimum isoform fraction (parameter ‘-F 0.01’) to report more splice
isoforms. For ISP, we extract introns directly from the isoforms predicted from the
multiple samples.
In the following sections we assess the accuracy of intron selection as a general
indicator for the programs’ ability to reconstruct as complete as possible a set of
transcripts and to detect splicing variation.
2.2.2.1 Performance on simulated data
We simulated 25 RNA-seq samples, each with roughly 85.9 million 100 bp paired-
end reads, starting from the expression profile of GENCODE v.22 [41] genes and
transcripts in five hippocampus samples (data not shown) and using the program
Polyester [42]. Polyester incorporates typical biases from library preparation and
sequencing, generating reads from the reference genome and randomly introducing
errors. Reads were mapped to the entire human genome (GRCh38) using TopHat2
(v2.1.0). For illustration purposes, we restricted our analysis to reads mapping to
chromosome 12. For evaluation, we consider GENCODE junctions contained in the
reads for each sample as the gold reference, and declare a match between a predicted
feature and a reference intron if their genomic coordinates match exactly. Hence, a
predicted intron is a true positive (TP) if it exactly matches an intron in the reference,
a false positive (FP) if it has no counterpart in the reference, whereas a reference
intron is deemed a false negative (FN) if it was not reported by the program. We use
the standard sensitivity Sn = TP/(TP + FN) and precision Pr = TP/(TP + FP )
measures as well as the combined F − value = 2 ∗ Sn ∗ Pr/(Sn+ Pr) [43] to measure
accuracy.
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We first assessed the potential of methods to uncover introns from single samples
when using local information only versus information from multiple samples. When
each sample is considered individually, programs find between 7,795-10,113 (per sample
average) of the introns in a sample, for 78%-95% sensitivity, while precision is very high
for all programs, at >96% (Figure 2-4 and Table 2-I, column 2). JULiP’s sensitivity
is 16-30% higher than those of the single-sample assemblers, and a remarkable 13%
higher than the sensitivity of the multi-assembler ISP.









































Figure 2-4. Sensitivity (A) and precision (B) of programs for each sample. Per sample
precision cannot be calculated for ISP and JULiP, as they have access to additional
information and predict true introns in the simulated model that may not have been
sampled in an individual data set. Boxplots indicate the minimum, maximum and median
values, and the .25 and .75 quantiles for each program over the 25 samples. Circles indicate
the values for the pooled set of samples.
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Set TP (sample avg.) TP FP Sn Pr F-val
Gold reference 10,659 12,996 NA NA NA NA
Cufflinks 7,795 9,832 248 0.757 0.975 0.852
CLASS2 8,193 10,194 51 0.784 0.995 0.877
StringTie 8,245 10,093 29 0.777 0.997 0.873
Cufflinks_F001 8,749 10,601 506 0.816 0.954 0.880
CLASS2_F001 8,593 10,418 61 0.802 0.994 0.888
StringTie_F0.01 8,575 10,462 50 0.805 0.995 0.890
FlipFlop 8,351 10,214 2,437 0.786 0.807 0.797
ISP 8,961 9,949 187 0.766 0.982 0.860
JULiP 10,113 11,628 182 0.895 0.985 0.938
Table 2-I. Performance of methods on the simulated data. TP = true positives, per
sample average (column 2) and pooled across all samples (column 3); FP = false positives;
Sn = TP/(TP + FN), Pr = TP/(TP + FP) and F-val = 2 * Sn * Pr/(Sn + Pr).
Even when junctions are pooled across all samples, JULiP significantly outperforms
all other methods (Table 2-I, columns 3-7). It detects 89.5% of the introns encoded
in the data, compared to 81.6% or lower for the rest of the methods, at higher
or comparable precision (98.5%). Therefore, JULiP takes advantage of the latent
information in multiple samples to improve the sensitivity and precision of predictions
simultaneously and in a significant way.
Last but not least, JULiP found a total of 11,628 of the 12,996 introns generated
by the simulator, which is >30% more introns than found on average by any of
the other programs in a single sample. This difference represents introns missed by
the conventional assemblers but also new introns, i.e. which were included in the
simulation set but are not present in that sample, thus illustrating the power of a
multi-sample approach.
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Genes detected Genes detected
only by JULiP only by the counterpart
JULiP vs CLASS2_F001 136 2
JULiP vs StringTie_F001 193 4
JULiP vs Cufflinks_F001 218 1
JULiP vs FlipFlop 252 4
JULiP vs ISP 129 2
Table 2-II. Performance in gene detection.
To more specifically assess the contribution to gene and transcript reconstruction,
we mapped the introns found from the pooled data back to the reference annotations
to determine the set of genes they represent. In pairwise comparisons, JULiP found
between 129-252 genes that were not discovered by the other method, and only missed
1-4 genes in each comparison (Table 2-II). Therefore, JULiP was significantly more
sensitive and more robust in detecting the genes expressed in the set of samples,
utilizing the hidden information from multiple samples to identify genes with weak
signal that could not be detected by other methods.
2.2.2.2 Performance on real data
To observe the behavior of programs in a more realistic setting, we applied all methods
to 50 randomly chosen lymphoblastoid RNA-seq samples sequenced as part of the
GEUVADIS population variation project [25]. Samples contained between 23-57
million 75 bp paired-end Illumina reads. As before, we mapped all reads to the
reference genome with TopHat2, and extracted alignments on chromosome 12 for
analysis.
Unlike with simulated data, the true set of introns in the samples is not known. As
a notable consequence, it is impossible to distinguish between novel junctions not yet
recorded in the annotations and artifacts, or false positives. Nevertheless, we compile a
comprehensive reference set of introns from transcript annotations in the GENCODE
v.22, RefSeq and KnownGenes repositories, the latter two obtained from the Genome
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Browser at the University of California Santa Cruz (http://genome.ucsc.edu).
Set TP FP Sn Pr F-val Sn’ Pr’ F’-val
Reference 20,171 NA NA NA NA NA NA NA
Cufflinks 9,507 2,424 0.471 0.797 0.592 0.575 0.971 0.722
CLASS2 9,917 3,351 0.492 0.747 0.593 0.633 0.962 0.763
StringTie 9,206 1,948 0.456 0.825 0.588 0.550 0.994 0.708
Cufflinks_F001 10,883 8,739 0.540 0.555 0.547 0.842 0.866 0.854
CLASS2_F001 10,521 5,286 0.522 0.666 0.585 0.737 0.940 0.826
StringTie_F001 9,688 3,089 0.480 0.758 0.588 0.629 0.992 0.770
FlipFlop 9,960 13,656 0.494 0.422 0.455 0.684 0.584 0.630
ISP 9,030 1,723 0.448 0.840 0.584 0.507 0.952 0.662
JULiP 11,846 5,049 0.587 0.701 0.639 0.825 0.985 0.898
Table 2-III. Performance of programs on the GEUVADIS data set. Except for ISP and
JULiP, introns were pooled across all samples. Sn (Pr) = sensitivity (precision) on the
combined GENCODE, KnownGenes and RefSeq reference database; Sn’ (Pr’) = potential
sensitivity (precision) with additional EST, mRNA and multi-sample support.
Programs report between 9,000–12,000 junctions across all samples, with sensitivity
values ranging between 45.6% and 58.7%, where JULiP is the most sensitive of the
programs while ISP and StringTie are the least sensitive (Table 2-III). Precision varies
more widely across methods, with StringTie and ISP seemingly being the most precise.
Even so, JULiP has the best overall accuracy as measured by the F-value, 4% more
than the runner ups, CLASS2 and Cufflinks. We hypothesize, however, that most
of the additional introns predicted by JULiP are in fact true but unannotated splice
junctions.
Set FP ESTs, mRNAs ≥2 samples ≥5 samples Explained
Cufflinks 2,424 295 1,493 941 0.738
CLASS2 3,351 344 2,160 1,258 0.747
StringTie 1,948 278 1,326 916 0.823
Cufflinks_F001 8,739 665 4,770 2,360 0.622
CLASS2_F001 5,286 487 3,361 1,876 0.728
StringTie_F001 3,089 412 2,168 1,440 0.835
FlipFlop 13,656 495 2,845 1,673 0.245
ISP 1,723 146 913 516 0.615
JULiP 5,049 546 3,698 2,003 0.841
Table 2-IV. False positive introns explained by other data sources.
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To test this assumption, we searched the predicted but unexplained introns for
all programs against the collection of introns extracted from spliced alignments of
ESTs and full-length mRNA sequences, obtained from the UCSC Table Browser.
Also, introns that occur in two or more of the samples are more likely to represent
true but rare or cell type specific introns, not yet included in the databases. These
two categories accounted for more than 84% of the unannotated introns predicted
by JULiP, and smaller fractions for the other programs (Table 2-IV). When these
additional introns are considered, the fraction of predicted introns for each program
(Table 2-III, Sn′) grows to 50.7–82.5%, and similarly for precision (Pr′), 58.4–99.2%.
JULiP has slightly lower sensitivity than Cufflinks_F001, which is the most sensitive,
however its precision is higher by a significant 12%, namely 98.5% compared to 86.6%.
Overall, JULiP once again has the best F-value, 89.8%, and has the best tradeoff
between sensitivity and precision, and therefore is the method best suited to extract
splice information from the large collection of RNA-seq data.
2.2.2.3 Scalability with large collections of data
To test JULiP’s scalability with large collections of RNA-seq data, we simulated
100 samples using the protocol earlier. We tested the parallel version of JULiP on
the Johns Hopkins University MARCC computing cluster, using 20, 40, 60, 80 and
100 simulated samples, with varying levels of resources. Tests were performed on
4 Linux cluster nodes with 24 cores each, to capture the potential of JULiP under
a resource-rich scenario, and on a single 24-core node, to assess performance under
a typical bioinformatics computing environment. For comparison, we also ran the
non-parallel, single-threaded version of JULiP on all data sets. All nodes had 2.5 GHz
CPUs and 128 GB of memory.
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No. samples 20 40 60 80 100
4 x 24 CPUs 1m1.5s 1m8.3s 1m22.0s 1m41.0s 1m54.3s
(0m38.1s) (0m41.5s) (0m51.8s) (1m7.3s) (1m17.2s)
1 x 24 CPUs 1m14.0s 2m15.1s 3m11.9s 4m12.5s 5m15.9s
(0m50.3s) (1m37.8s) (2m21.9s) (3m7.9s) (3m50.4s)
1 x 1 CPU (1 thread) 6m14.7s 12m20.1s 18m21.8s 24m11.9s 29m15.8s
(1m39.2s) (3m19.3s) (4m32.7s) (5m58.9s) (7m38.9s)
Max memory 597 Mb 605 Mb 608 Mb 607 Mb 616 Mb
Table 2-V. Run time and memory requirements for JULiP with 20, 40, ... , 100 simulated
data sets with varying resource levels (Numbers in parentheses indicate run times for the
LP solver only).
JULiP took less than 2 minutes to complete each run in the resource-rich envi-
ronment, and less than 6 minutes on the 24 CPU single server (Table 2-V). Most
importantly, JULiP took less than 30 minutes to complete the largest run sequentially,
of which only 7m39s solving the LP problems and the rest preparing the read count
and region information. Therefore, JULiP can be used on a variety of computing
platforms and with varying amounts of resources, from a single desktop to large-scale
computing clusters. In contrast, Cufflinks, CLASS2 and StringTie took roughly 20, 12
and 10 minutes per sample on average, all with 4 threads, FlipFlop required more than
7 hours per sample single-threaded, and ISP took 1h 10min with 48 threads for the 25
sample data set. While these numbers are not directly comparable, they showcase the
capabilities and potential of JULiP to perform calculations on very large collections
of data.
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2.3 JULiP2: A robust model for intron selection
and detection of differential alternative splic-
ing from multiple RNA-seq samples
Once an accurate set of features is generated, the next step in an RNA-seq analysis
involves comparing and identifying differences in usage between two conditions. To
address this problem, we developed the JULiP2 method that incorporates differential
splicing detection. Additionally, the Poisson read count model in JULiP may not be
suitable to capture the over-dispersion in some biological data; therefore, in JULiP2 we
formulated a new intron selection method, based on the negative binomial distribution
to model read counts.
JULiP2 detects introns from the read alignments and uses the read counts of
splice junctions to estimate the relative expression of introns under the experimental
conditions. JULiP2 adopts a generalized linear model (GLM) to model read counts
and test for differential usage of individual introns for each gene. More specifically,
to detect differential isoform usage represented as differential intron abundance in
different conditions, JULiP2 tests for differentials in read counts supporting splice
junctions (introns). Testing for differential usage of introns, compared to whole
isoforms or even local alternative splicing events, has a number of benefits. Introns as
splicing events are discrete and identifiable, capture a variety of splicing patterns, and
make it easy to incorporate novel splicing variants. This allows us to indirectly query
for differential regulation in unknown isoforms, improving performance on unknown
genes or sparsely annotated genomes.
Following the general approach of its predecessor JULiP, JULiP2 extracts the
introns in a gene region from read alignments, calculates the read counts for these
introns, and fits the values to a generalized linear model (GLM). In the model, the
parameters mean µ and variance σ are estimated, and then tested by a likelihood
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ratio test to detect differences between conditions, using the p-value of the test to
report statistically significant results.
JULiP2 has the following key features that distinguish it from other similar RNA-
seq analysis methods:
• JULiP2 can be run without a reference annotation, accurately detecting novel
splice junctions as well as infering gene regions, which benefits analyses where
the available transcript annotation is flawed or incomplete.
• JULiP2 can detect differentials in novel introns without the need for an additional
isoform assembly step or the assistance of a reference annotation.
• JULiP2 is efficient, lightweight and faster than existing approaches while provid-
ing estimates of equal accuracy and substantially reducing parametric complexity.
2.3.1 Methods and implementation
2.3.1.1 Core statistical methodology
We assume the RNA-seq reads are generated independently for each samples. Given a
gene region, we define a set of observation X = {xsv|v ∈ V, s ∈ S}, where V is a set of
candidate introns, S is the sample set, and xsv is a random variable representing the
splice junction reads counts of intron v in sample s. Unlike the Poisson regression model
in JULiP with the assumption that variable xsv has equal mean and variance. Here,
we consider an over-dispersion model that variance can differ from the mean, because
of our observations of the real RNA-seq data, which almost reject the restriction that
the variance equals to the mean.
In detail, we assume xsv follows a negative binomial distribution (NB) with mean
µsv and variance σsv,
xsv ∼ NB(µsv, σsv)
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It is natural to model the variance σ as a function of the mean, σ = µ + αµ2,
where α is the dispersion parameter.
The joint distribution of P (X|µ, α) can be represent as,
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Where Γ() is the gamma function. Taking the logarithm with respected to all
samples and splice junctions in given gene region,












(log(Γ(xsv + α−1v )) − log(Γ(xsv + 1)) − log(Γ(α−1))
− (xsv + α−1v )log(1 + αvµsv) + xsvlog(αvµsv))






(log(Γ(α−1v ))−log(Γ(xsv+α−1v ))+(xsv+α−1v )log(1+αvµsv)−xsvlog(αvµsv))
The splice junction representing the true introns should be consistent and significant
between replicates. We use a single parameter βv to represent µsv (µsv = βv) for splice
junction (intron) v across multiple samples and the above equation can be simplify as,






(log(Γ(α−1v )) − log(Γ(xsv + α−1v )) + (xsv + α−1v )log(1 + αvβv) − xsvlog(αvβv))
2.3.1.2 Model for intron detection
For the intron detection task, the total number of candidate splice junctions collected
from all samples is large, but only a few splice junctions are expected to be real.
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Therefore, the solution must be sparse, and we can use L1(Lasso) regularization to
encode sparseness. Together with L(β, α), we propose:
J(β, α; t) = L(β, α) + tβ||β||1 + tα||α||1
where t = (tβ, tα), t > 0 is the regularization parameter. Since β ≥ 0 and α ≥ 0,









Finally, for intron detection task, the optimization problem can be expressed as:
argminβ,αJ(β, α; t)
s.t. t > 0
β ≥ 0
α > 0
2.3.1.3 Model for differential splicing
To further estimate differential usage of introns and gene expression in different
condition groups, we redesign the mean µsv to include more information. Specifically,
µsv is predicted via a log-linear model, log µsv = β1 +β2 +β3 + · · · , where the parameter
βi is used to model the potential factors of interest. The factors we considered for
our model included (1) the fraction of the reads mapped to splice junction, βv; (2)
the sample the reads came from, βs; (3) the treatment condition, βcv; (4) the control
condition, βtv; (5) the baseline expression strength of the gene, βg; (6) the fraction of
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the reads mapped to the gene that overlap with the splice junction, βfg; and (7) the
logarithm of the fold change in the overall expression of the gene, βfcg. We evaluated
multiple combinations of parameters and parameter values, to select a subset that
had a critical impact on the results, which led to:
log µsv = βv + βs + βcv + βtv
Where, µsv is decompose into four factors, βv is the logarithm of the expected
fraction of the reads mapped to splice junction v. βs is the logarithm of the expected
fraction of the reads came from sample s, βtv is the effect of the test condition has
on the fraction of reads falling into splice junction v. βcv is the effect of the control
condition has on the fraction of reads falling into splice junction v. hence, L(µ, α)
change to,





(log(Γ(α−1v )) − log(Γ(xsv + α−1v ))
+ (xsv + α−1v )log(1 + αvexp(βv + βs + βcv + βtv))
− xsvlog(αvexp(βv + βs + βcv + βtv)))
s.t. βv, βs, βcv, βtv ≥ 0
αv > 0
2.3.1.4 Implementation and parameter selection
Like JULiP, JULiP2 works in four phases:
(1) construct the set of candidate introns and their read counts;
(2) detect mapping regions and merge into gene regions;
(3) for the intron detection task, estimate intron abundance using the GLM and select
an optimal set of introns;
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(4) for the differential analysis task, estimate the differential usage of introns by GLM
coupled with a Wald test.
In step 1, a list of RNA-seq BAM files and optionally a transcriptome database
are accepted as the JULiP2 input. A set of candidate introns and their read counts
in each sample are inferred from the spliced alignments (in BAM file). To reduce
ambiguity due to reads mapping to multiple locations, we use the count of primary
mapping reads.
In step 2, if a transcriptome database is provided, genes and exons info will be
extracted, otherwise, genic and exonic regions will be inferred by JULiP2. For the
inference, overlapping read alignments in each sample are merged to form contiguous
exonic regions. Exonic regions from individual samples are then merged across all
samples and used as ‘bins’ for clustering introns. Exonic regions are further connected
via the candidate introns from step 1 into larger gene regions. This process may create
long regions that contain several genes. Large ‘bins’ harboring hundreds of introns can
significantly affect performance as well as the accuracy of the program, for instance
when genes with varying expression levels are being clustered together. Therefore, an
optional approach can be adopted to split regions. The idea is to cut region if intron
counts change abruptly over a fixed window.
In step 3, the model selects a subset of candidate introns believed to be expressed
in the samples and estimates their abundance levels, using the L1-regularized linear
program described in the previous section. The algorithm iteratively estimates the
abundance ratio β of introns based on their read counts. The process updates β and
reduces the regularization parameters t accordingly, and is iterated until convergence.
In step 4, the GLM algorithms described in the previous section are used to
reconstruct the read counts of introns under the null and the alternative hypotheses.
The null hypothesis is that there is no difference in intron usage between the conditions,
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while the alternative hypothesis assumes some introns are differentially used between
the two conditions. A likelihoood ratio test is applied to evaluate the results. A
p-value is calculated on each intron within a gene and a Benjamini-Hochberg (BH)
correction for multiple testing is used to reduce the false discovery rate and calculate
a gene-wise q-value.
JULiP2 is designed take advantage of multiple CPU cores and scales well with
the input RNA-seq alignment data. JULiP2 can quantify abundance from pre-
computed alignments provided in SAM or BAM format. JULiP2 is written in Pyhton,
is open-source and free licensed (GPL v3). It has been developed and tested on
Linux and Macintosh OS X. The software and user manual are freely available at
https://github.com/Guangyu-Yang/JULiP2 .
2.3.2 Evaluation
2.3.2.1 Performance of feature selection
We used the framework developed for evaluating JULiP, including measurements on
both simulated and real data, to compare the performance of JULiP2 vis-à-vis its
predecessor and several transcript assembly methods, including Cufflinks, CLASS2,
StringTie, FlipFlop and the multi-sample assembler ISP. As before, introns were
extracted from transcript predictions for the single-sample assemblers and were then
combined across all samples, whereas for the multi-assembler ISP introns were extracted
from the reported joint transcript set. For JULiP2, we used four types of models and
parameter values for estimating the parameters of the negative binomial distributions
(nb1-4).
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Set TP FP Sn Pr F-val
Gold reference 12,996 NA NA NA NA
Cufflinks 9,832 248 0.757 0.975 0.852
CLASS2 10,194 51 0.784 0.995 0.877
StringTie 10,093 29 0.777 0.997 0.873
Cufflinks_F0.01 10,601 506 0.816 0.954 0.880
CLASS2_F0.01 10,418 61 0.802 0.994 0.888
StringTie_F0.01 10,462 50 0.805 0.995 0.890
FlipFlop 10,214 2,437 0.786 0.807 0.797
ISP 9,949 187 0.766 0.982 0.860
JULiP 11,628 182 0.895 0.985 0.938
JULiP2 (nb1) 12,089 294 0.930 0.976 0.953
JULiP2 (nb2) 11,899 235 0.916 0.980 0.947
JULiP2 (nb3) 11,671 212 0.898 0.982 0.938
JULiP2 (nb4) 11480 185 0.883 0.984 0.931
Table 2-VI. Performance of JULiP2 (versions nb1, nb2, nb3 and nb4) and other methods
on 25 simulated RNA-seq data sets.
The first, accuracy test, on 25 simulated RNA-seq samples, showed JULiP2 to
achieve better or comparable results with JULiP, as measured by the F-value as well
as by the individual sensitivity and precision measures, and both JULiP programs in
turn were significantly more sensitive than the other methods, namely >30% more
than the most sensitive single-sample method, and 10% more introns in the cumulative
set of samples (Table 2-VI). The second test, on real data, assessed the programs on
50 RNA-seq data sets from lymphoblastoid RNA-seq samples sequenced as part of
the GEUVADIS population variation project. JULiP2 detected a number of known
introns comparable to JULiP, but produced a larger number of additional introns,
apparent false positives. Most of the additional introns, however, could be explained by
new sources of information (dbEST, GenBank RNA-seq, recurrence), thus rendering
JULiP2 as the tool with the highest capacity for finding intron features (Table 2-VII).
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Set TP FP Sn Pr F-val Sn’ Pr’ F-val’
Reference (GENCODE) 20,171 NA NA NA NA NA NA NA
Cufflinks 9,507 2,424 0.471 0.797 0.592 0.575 0.971 0.722
CLASS2 9,917 3,351 0.492 0.747 0.593 0.633 0.962 0.763
StringTie 9,206 1,948 0.456 0.825 0.588 0.550 0.994 0.708
Cufflinks_F0.01 10,883 8,739 0.540 0.555 0.547 0.842 0.866 0.854
CLASS2_F0.01 10,521 5,286 0.522 0.666 0.585 0.737 0.940 0.826
StringTie_F0.01 9,688 3,089 0.480 0.758 0.588 0.629 0.992 0.770
FlipFlop 9,960 13,656 0.494 0.422 0.455 0.684 0.584 0.630
ISP 9,030 1,723 0.448 0.840 0.584 0.507 0.952 0.662
JULiP 11,846 5,049 0.587 0.701 0.639 0.825 0.985 0.898
JULiP2 (nb1) 11,954 10,526 0.593 0.532 0.561 0.995 0.893 0.941
JULiP2 (nb2) 11,631 7,336 0.577 0.613 0.594 0.909 0.967 0.937
JULiP2 (nb3) 11,271 5,433 0.559 0.675 0.611 0.821 0.992 0.898
JULiP2 (nb4) 10,967 4,390 0.544 0.714 0.617 0.759 0.995 0.861
Table 2-VII. Performance of JULiP2 (nb1, nb2, nb3 and nb4) and other methods on the
GEUVADIS data set (50 lymphoblastoid RNA-seq samples).
2.3.2.2 Performance of differential splicing on simulated data
We evaluated the performance of JULiP2, comparing it with the programs JunctionSeq,
rMATS, LeafCutter and MAJIQ for the differential analysis task, and with Cufflinks,
Stringtie, and CLASS for the intron detection task. All the approaches were run with
the default settings in the experiments.
We first evaluate the programs in a controlled setting where the true transcripts’
expression and splicing levels are known. For this task, we generate 50 synthetic
samples (7 million 101 bp paired-end reads/sample) by Polyester. The simulator
was trained on GenBank SRR493366 reads, with gene expression levels (in FPKM)
estimated with Ballgown [44] from Tophat2 alignments. For the simulation pipeline,
we randomly select 2000 protein coding genes from among those containing at least
two different expressed isoforms. We set the expression levels of the selected genes in
the control samples to be the same as in the original sample. For the ‘test’ samples,
we assign the selected protein coding genes into 4 groups, each with 500 genes, as
follows. 1) The first group had no change in FPKM values. 2) For the second group,
we simulated differential gene expressions (DE) by changing (doubling or halving) the
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FPKM values of the genes, randomly. 3) In the third group, we simulated differential
splicing (DS) by swapping the expression levels of the two most highly expressed
isoforms for the gene. 4) In the fourth group, we applied the modification in 2) and 3)
to create a mixture of differential expression and differential splicing events.
A true positive (TP) occurs when the prediction matches the gene settings, a
false positive (FP) when the prediction does not appear in the gene settings, and
lastly, a false negative (FN) occurs when a true differential event is not reported by
the program. We calculate the standard sensitivity, precision and the F-value for
each program. As seen in (Figure 2-5A), JULiP2 has the best performance in our
testing, and sensitivity, precision and F-value are all very high. Of the programs
tested, only JunctionSeq achieves a similar level of performance, but we note that
JunctionSeq incorporates external information about the annotations and exon counts.
Additionally, as a drawback, JunctionSeq has a large running time and cannot process
large datasets.
2.3.2.3 Performance of differential splicing on real data
Further, to test the programs for their abilities in detecting differential splicing events
in a real setting, we ran JULiP2, rMATS, MAJIQ and LeafCutter on an RNA-seq data
set from hippocampus tissue of healthy and epileptic mice (PRJEB18790) [45]. We
used 10 randomly selected control samples and 10 epilepsy samples. We aligned the
reads with STAR [46] and applied each method to identify splicing differences between
the two conditions (chr2 only, for simplicity). Figure 2-5B shows the correspondence




Figure 2-5. Evaluation of differential splicing prediction methods. (A) Simulated data:
2D column plots of the sensitivity, precision and F-values for the selected programs. The
p-value thresholds are chosen based on the recommendation in the papers. (B) Real data:
Correlations of differential splicing predictions by different methods.
2.3.2.4 Detection of non-canonical splice junctions from a collection of
human liver RNA-seq data
To further assess the usefulness of our method, we applied JULiP2 to a collection
of post-mortem human liver tissue samples from individuals with mental illness
(schizophrenia, 21 samples) and unaffected controls (17 samples) (GenBank accession:
PRJNA575230). We chose to focus on non-canonical splice junctions because they are




JULiP2 (β ≥ 0.1) 195,938 5,328
JULiP2 (DS, sufficient input) 183,632 3,457
Context (C=1) 182,136 3,445
Diff. spliced 11,258 720
Table 2-VIII. Non-canonical intron detection and selection from 21 RNA-seq liver samples
from schizophrenia and 17 unaffected individuals.
Specifically, our approach was as follows (Table 2-VIII). We used STAR to generate
genome-wide spliced alignments, from which we extracted candidate splice junctions
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(introns) with the tool ‘junc’ [18], modified and included in the JULiP2 package. This
procedure generated 1,058,787 splice junctions across all samples, including 382,272
candidate non-canonical (NC) splice junctions. To reduce the number of false positive
NC junctions and select an accurate subset for further investigation, we applied a three
step filtering procedure. First, we employed the alignment-based filters implemented
in the tool ‘junc’ to remove alignment artifacts, namely inconsistent mappings between
reads within the same pair, reads with low alignment scores, and reads from non-
concordant pairs. This step reduced the number of unique introns to 830,791, including
154,276 NC introns. Second, we applied the intron selection procedures implemented
in JULiP2 to select a subset of high-confidence introns (183,632 introns, of which
3,457 non-canonical). Third, we selected only those introns that were identified as
‘reliable’ based on sufficient original read mapping support in at least C samples
(default: 1). This resulted in 183,136 introns, including 3,445 NC introns. Of these
remaining candidates, we further prioritized 720 putative NC junctions that JULiP2’s
differential splicing module identified as differentially spliced between schizophrenic
and unaffected individuals (C = 1). Figure 2-6 shows the alignments of one such
example, intron chr6:25137823-25138073 with the genomic signal CT-GC (GC-AG on
the gene’s strand) at the CMAHP gene.
2.4 Discussion
In this section, we described JULiP and JULiP2, two novel methods for intron
selection from multiple RNA-seq samples and for differential splicing detection. The
methods simultaneously model splice junction information across the samples into
linear models, namely a regularized linear program for JULiP and a GLM for JULiP2,
taking advantage of the latent information in the set of samples to extract a highly
accurate set of introns.
When evaluated on simulated data, JULiP significantly outperformed current
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Figure 2-6. IGV plot showing the non-canonical splice signal CT-GC at the CMAHP
gene.
assembly based approaches in the ability to select an accurate set of features (introns).
In particular, JULiP could identify 16-30% more introns from a single sample compared
to reference (single-sample) programs at precision comparable to the highest, and
9-18% more features when introns were pooled together across all samples. When
applied to real data, JULiP had the highest potential to identify splice variation from
multiple samples, demonstrating both high sensitivity and very high precision, >98%.
An implementation of JULiP using the Hadoop parallel framework scaled well
with the number of nodes and samples, and ran in under 2 minutes for up to 100
samples. Therefore, JULiP provides a highly efficient model for intron selection from
multiple, potentially hundreds and thousands of RNA-seq samples, and can be used
as a standalone tool or can be efficiently integrated into a transcript assembly method
for comprehensive annotation of splice variation.
While JULiP is restricted to the problem of intron selection, JULiP2 offers a more
comprehensive and flexible approach, with the addition of a differential splicing model
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and a more realistic read count model based on the negative binomial distribution.
The negative binomial distribution facilitates an intuitively interpretable separation
of biological from technical variation, while the GLM allows for arbitrarily complex
experiments.
Using both simulated and real data, we benchmarked JULiP2 against Cufflinks,
Stringtie, and CLASS for the intron detection task, and against CuffDiff, JunctionSeq,
and DEXSeq for the differential analysis task. The experiments demonstrated that
our method has high sensitivity and precision, while better controlling the rate of false
positives.
In summary, both JULiP and JULiP2 are novel and representative models for
leveraging latent gene information from multiple related RNA-seq samples to signif-
icantly increase the accuracy of feature selection. Additionally, JULiP2 provides a
robust and flexible framework for differential splicing analysis at the intron level. Our
tools are annotation and assembly free, and therefore avoid the pitfalls of assembly
while allowing for the detection of new splice variants. Lastly, they are lightweight,
memory efficient and highly scalable, offering a powerful and practical solution for the




In Chapter 2, we discussed JULiP and JULiP2 and their applications to intron selection
and differential splicing analysis. While our assessments indicate that JULiP and
JULiP2 perform well, there are still limitations. For instance, because they rely on
the gene context for estimating intron parameters and for testing, their performance
suffers when used without a reference gene annotation to accurately determine the
boundaries of the gene. To address this and other challenges, we developed MntJULiP,
a comprehensive and scalable tool for differential splicing detection at the intron
level, based on generalized linear models. Further, there is a scarcity of tools to
present differential splicing events to biologists in an intuitive way. To fill this gap, we
developed the visualization toolkit Jutils, to create representations of results produced
by MntJULiP and other differential splicing tools as heatmaps, sashimi plots and
Venn diagrams.
3.1 Background
Gene alternative splicing is a fundamental biological process that gives rise to a wide
array of protein isoforms with modified properties in plant and animal systems. Most
splicing variations are tissue specific, but splicing is also altered by external stimuli [15]
and aberrant splicing has been associated with diseases [31]. Therefore, there is a
41
great need to accurately map and quantify gene splice variants, as well as to identify
differences in splicing between conditions.
As described in Chapter 2, current methods for differential splicing detection can
detect and quantify alternative splicing from RNA sequencing (RNA-seq) data at the
level of transcripts (isoforms), splicing events (exon skipping, mutually exclusive exons,
alternative exon ends, intron retention), or primitive features (subexons, introns).
Isoform-level quantification methods (Cuffdiff, Cuffdiff2, MISO [17, 32, 47]) require
a reference annotation or a reconstructed set of transcripts, and their performance
suffers from incompleteness and inaccuracies in the assemblies. Event level methods
(DiffSplice, rMATS [23, 33]) are less affected by assembly errors, but represent only a
subset of alternative splicing variations. For both of these methods, quantification is
further complicated by the ambiguity in assigning reads that map to multiple locations
in the genome and multiple transcripts of a gene. In contrast, more recent methods
(LeafCutter, MAJIQ, JunctionSeq [34, 37, 38]) target introns, which can be more
reliably identified from read alignments, capture a wider variety of splicing variations,
and are less ambiguous to quantify, as intron-spanning reads associate with unique
gene splice patterns.
Methods further differ in how they define splicing differences. Most methods
quantify changes in the relative splicing levels of the target feature within a group of
mutually exclusive local splicing patterns (LeafCutter, MAJIQ, rMATS, DiffSplice),
or alternately identify features with splicing usage inconsistent with the rest of the
gene (JunctionSeq, DEXseq [48]). Yet others look for changes in the overall (absolute)
abundance levels, as a means to identify changes in isoform regulation leading to
functional effects (Cuffdiff, Cuffdiff2, ALEXA-seq [17, 32, 49]).
Lastly, to increase accuracy, some methods rely on a pre-existing set of gene
annotations to identify relevant splicing variations, limiting discovery of novel and
potentially condition-specific features. The rich spectrum of methods for alternative
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splicing quantification and differential analysis offer a multifaceted yet inconsistent
view of alternative splicing variation [50].
3.2 MntJULiP: Comprehensive and scalable quan-
tification of splicing differences from RNA-seq
data
We introduce MntJULiP, a statistical learning method based on a novel mixture
Bayesian framework, for detecting differences in splicing between large collections
of RNA-seq samples. MntJULiP represents splicing variation at intron level, thus
capturing most splicing variations while avoiding the pitfalls of assembly. It infers
intron annotations directly from the alignments, making it possible to discover new
unannotated candidate markers. MntJULiP detects both differences in intron splicing
levels, herein called differential splicing abundance (DSA), and differences in intron
splicing ratios relative to the local gene output, termed differential splicing ratio (DSR)
(Figure 3-1). Salient features of MntJULiP include: i) a novel statistical framework,
including a zero-inflated negative binomial mixture model for individual introns, in
the DSA model, and a Dirichlet multinomial mixture model for groups of alternatively
spliced introns, in the DSR model; ii) it captures significantly more alternative splicing
variation, and more types of variation, than existing tools; iii) superior performance
compared to reference methods, including increased sensitivity in control experiments,
and high reproducibility and reduced false positives in comparisons on real data; iv) a
unique mixture model that allows comparison of multiple conditions simultaneously, to
aptly capture global variation in complex and time-series experiments; and v) highly
scalable, it could process hundreds of GTEx samples in less than half an hour.
MntJULiP differs from and improves upon the model implemented in JULiP and
JULiP2 in multiple ways. The main difference is that, unlike JULiP and JULiP2
that jointly model the set of all introns at a gene, MntJULiP targets individual
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introns (DSA) or groups of introns that share the same splice site (DSR). In this way,
MntJULiP can extract splicing events directly from the RNA-seq alignments, without
the need for a reference gene annotation. Moreover, such setup can avoid grouping
large numbers of introns from a gene region, which usually results in poor performance
for some low expressed splice junctions or genes. Further, unlike JULiP/JULiP2 that
select introns directly via the L1 regulated model, MntJULiP can be used for intron
selection in an implicit way. Specifically, the MntJULiP DSA model estimates the
mean expression level of an intron in given condition(s), which it then uses to filter out
introns below a user specified threshold, likely caused by ’noise’ or alignment errors.
3.2.1 Methods
MntJULiP consists of two components, a ‘builder’ and a ‘quantifier’. The builder
takes as input the aligned RNA-seq reads, extracts the splice junctions (introns) and
their supporting read counts, and filters introns with low support (≤ 3 reads in each
of the samples). A second, context-based filter for low support introns is embedded
in the statistical model below. Individual introns are the subject of DSA analysis.
For the DSR analysis, introns that share an endpoint are grouped into ‘bunches’.
If a reference gene annotation is provided, both individual introns and bunches are
associated with an annotated gene if they share at least one intron coordinate. The
quantifier subsequently evaluates candidate introns, building a learning model for each
intron and performing two statistical tests: i) a test for a change in intron abundance
between the two (or more) conditions (DSA), and ii) a test for a change in the splicing
level of the intron relative to its ‘bunch’ (DSR). For DSA, MntJULiP uses a mixture
zero-inflated negative binomial model to estimate individual introns’ abundance levels
from the raw read counts. For DSR, it estimate the relative splicing ratios with a
mixture multinomial Dirichlet distribution. In both models, log-likelihood ratio tests
are used to determine differential splicing events. P-values are then adjusted for
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Figure 3-1. (A) RNA-seq reads are aligned to the genome and spliced alignments are used
to detect the genomes and calculate their read counts. MntJULiP then tests individual
introns for differential intron abundance (DSA), and groups of introns sharing a splice site
(’bunches’) for differential splicing ratio (DSR). (B) Left, DSA: Each intron is analyzed
individually, and the expression (abundance) level is compared between conditions. Right,
DSR: Introns that share a splice junction (‘bunch’) are collectively analyzed, and the PSI
value for each intron is compared between conditions. Shown are: an individual exon
in a three-condition experiment, in the DSA diagram, and a three-intron ‘bunch’ in a
two-condition experiment, in the DSR diagram.
multiple testing using the Benjamini-Hochberg correction. The entire framework is
described in detail below.
45
3.2.1.1 Bayesian read count model
We use a Bayesian statistical framework to estimate intron splicing levels for differential
analyses. This framework also provides another way to distinguish true introns from
sequencing and systematic errors, as a second context-based intron filter. To start, we
assume that the read count y of intron v in a given sample follows a negative binomial
distribution NB(µ, θ). We next add a loose prior with an empirical µ̂ (the sample
mean) modeled by a normal distribution: µ ∼ N(µ̂,
√︂
µ̂/10) to model subtle variability
between conditions and among the individual samples, and a restriction to the dis-
persion parameter ϕ as an inverse Half-Cauchy distribution: ϕ−1 ∼ Half Cauchy(0, 5).
Lastly, to account for low expression genes and transcripts, and for low read count
introns from library preparation and sequencing artifacts, we introduce a zero inflated
modifier on the negative binomial Bayesian model [51]:
y ∼
⎧⎨⎩0, with probability πNB(y), with probability 1 − π
where NB(y) is the probability density function of the negative binomial model
described above.
Let p(y) denote the probability density function for this model. For n samples and
intron read count yj in sample j, we define the log likelihood:




We maximize the log likelihood function using the Limited memory Broyden Fletcher
Goldfarb Shanno (LM-BFGS) optimization method [52] and obtain point estimates
for parameter θ over the samples.
3.2.1.2 The differential splicing abundance (DSA) model
The previous section established a general Bayesian model to estimate intron abun-
dance. Next we describe the framework for modeling individual intron abundance and
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for DSA testing in a multi-condition experiment. Assume that samples are drawn
from m (typically 2) conditions. Given an intron v and a sample generated from
condition i, its intron read count y follows a negative binomial distribution NBi(y)
with the condition specific parameters µi, θi , ϕi and πi, as defined earlier.
Let pi(y) be the probability density function for the complete model for condition





where zi is the indicator variable for that sample, equal to 1 iff the sample belongs to
condition i and 0 otherwise.
To formulate the problem, given n samples, m conditions and yj the intron read
count in sample j ∈ {1, . . . , n}, we define the log likelihood:






with zij ∈ {0, 1} the indicator variable for sample j and condition i.
Having these two Bayesian models, we establish a hypothesis test for differential
intron abundance given the data: the null hypothesis is that samples are generated
from the same condition, and the alternative hypothesis is that the samples belong to
different conditions, and apply a likelihood-ratio test:
LR = −2[L(θ0) − L(θ1)],
where L(θ0), L(θ1) are the log likelihoods of the null and alternative hypothesis models,
respectively, with parameters θ0 and θ1 .
Lastly, since the parameter µj of the alternative hypothesis model is the expected
read count (mean) of the intron in condition j, we can establish an additional intron
filter by setting a threshold for µj (e.g., µj ≥ 1), to separate a ‘true’ intron from noise.
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3.2.1.3 The differential splicing ratio (DSR) model
We next formulate a framework to test for differences in splicing ratios of introns
within a ‘bunch’, or groups of introns sharing an endpoint. For simplicity, we start
by assuming that all samples belong to the same condition and the read counts
y1, y2, . . . , yk in a bundle with k introns follow a Dirichlet-multinomial distribution
with priors α1, α2, . . . , αk: y1, y2, . . . , yk ∼ DM(α1, α2, . . . , αk)
Let p(y1, y2, . . . , yk) be the probability density function. For intron read counts
(y1j, y2j, . . . , ykj) in sample j = 1, . . . , n, we define the log likelihood function:




Similar to the discussion in the previous subsection, to extend to the case where
samples belong to multiple conditions we define a Dirichlet-multinomial distribution
with prior αi1, αi2, . . . , αik for each condition i ∈ {1, . . . ,m}.
yi1, y
i
2, . . . , y
i
k ∼ DM(αi1, αi2, . . . , αik)
Let pi(yi1, yi2, . . . , yik) be the probability density function for condition i. We define
the log likelihood function






where yj = (y1j, y2j, . . . , ykj are the read counts of introns in the bundle in sample j,
zi,j ∈ {0, 1} indicates whether sample j belongs to condition i or not, and θ represents
the parameter set of the model.
With the two Bayesian models above, we formulate a log-likelihood ratio test
as before: the null hypothesis assumes all samples belong to the same condition,
and the alternative hypothesis assumes multiple conditions. Under the alternative
hypothesis, the parameters αi1, αi2, . . . , αik for condition i can be used to define the
splicing ratio, similar to Percent Splicing Inclusion [16, 38], Ψil of intron l ∈ {1, . . . , k}
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3.2.1.4 Sequences and materials
Simulated data. We generated 25 control and 25 perturbed RNA-seq samples with
86 million 101 bp paired-end reads each, using the software Polyester with human
GENCODE v.22 as reference annotation. For the control samples, we used a model of
gene and transcript abundance inferred from lung fibroblasts (GenBank Accession:
SRR493366). To simulate the perturbed condition, we randomly selected 2,000
annotated protein coding genes with two or more expressed isoforms and assigned
them to four groups as follows [37, 53]: i) 500 genes were left unperturbed (NONE);
ii) 500 genes had only expression changes (DE), where genes were randomly assigned
one half or double the original FPKM value; ii) 500 genes had only splicing differences
(DS), obtained by swapping the expression values of the top two isoforms; and iv)
500 genes had both expression and splicing changes (DE-DS). Thus, 1,500 genes
underwent changes in splicing abundance, and 1,000 had differences in splicing, and
were used as the gold reference for evaluating the tools under the DSA and DSR
models, respectively.
Real data. Reads for 44 mouse hippocampus samples (24 cases and 20 controls)
were obtained from GenBank (ProjectID: PRJEB18790). Tissue RNA-seq samples for
comparative analyses (121 cortex, 105 frontal cortex, 132 cerebellum, and 196 lung
samples) were obtained from the GTEx collection [27]. Lastly, RNA-seq data from
differentiating mouse taste organoids [54] (14 samples, 7 stages) were obtained from
the Sequence Read Archive (Accession: DRA005238).
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3.2.1.5 Performance evaluation
Reads were mapped with the program STAR v.2.4.2a to the human genome GRCh38
or mouse genome GRCm38 (mm10), as applicable. Alignments were analyzed with
the programs MntJULiP v1.0, LeafCutter v0.2.8, MAJIQ v1.1.7a, rMATS v3.2.5 and
Cuffdiff2 v2.2.1 to determine changes in alternative splicing profiles. For the simulated
tests, transcripts were reconstructed across each sample with StringTie v2.1.4 then
merged across samples with StringTie(ST)-merge and the GENCODE transcripts
as reference, to create a set of gene annotations to be used with all programs. To
evaluate the programs’ accuracy in predicting differentially spliced genes from the
simulated data, the 1000 (DS, DE-DS) gene set and the 1,500 (DS, DE, DE-DS)
gene set were used as the gold standard for DSR and DSA prediction, respectively.
Any other program predictions were deemed false positives. Standard sensitivity (Sn
= TP/(TP+FN)), precision (Pr = TP/(TP+SP)), and the F1 = Sn*Pr/(Sn+Pr)
value were used to measure accuracy. To assess the programs’ fidelity in quantifying
alternative splicing for the DSR test, reference Percent Splice Inclusion (PSI) values
for all reference introns were calculated from the simulated data, as the ratio between
the intron abundance and that of its bunch. Similarly, for the DSA test, reference
log fold change values were calculated for each intron as the log fold change of the
cumulative expression levels of all splice isoforms containing that intron.
3.2.2 Evaluation
We assess the performance of MntJULiP and other programs on simulated and
real RNA-seq data, with varying degrees of splice variation and different dataset
sizes. We illustrate MntJULiP’s ability to detect more types of alternative splicing
variation in the comparison of hippocampus samples from healthy and epileptic
mice. We then demonstrate MntJULiP’s unique capability for simultaneous multi-
condition comparisons in a 7-point time series experiment on differentiating mouse
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taste organoids, and its ability to handle large data sets on a large collection of RNA-
seq samples from four human tissues obtained from the GTEx project. We include
in the comparisons, as feasible, the state-of-the-art intron-based tools LeafCutter,
MAJIQ, JunctionSeq, and the event-based rMATS, and Cuffdiff2 as the only tool
among them compatible with the DSA test.
3.2.2.1 Performance on simulated data
In a first, controlled experiment we used simulated data, namely 25 control and 25
perturbed samples, to evaluate MntJULiP (DSR), MAJIQ, LeafCutter, and rMATS
in detecting differences in splicing ratios, and MntJULiP (DSA) and Cuffdiff2 in
detecting differences in splicing abundance (see Methods and Figure 3-2). On the
DSR experiment, MntJULiP(DSR) achieved sensitivity 74.5%, which was 8.0-60.0%
higher than its competitors, at very high and comparable precision, 97.4%. Notably,
Cuffdiff2, which was not designed as a DSR method, had the highest sensitivity
at 94.9%, however at a very significant drop in precision, to 46.4%. On the DSA
experiment, MntJULiP(DSA) had very high 97.9% sensitivity and 95.3% precision, to
Cuffdiff2’s values of 95.9% and 70.3%, respectively. Sensitivity of MntJULiP’s DSA
test was also significantly higher than any of the DSR programs’, which ranged between
31.7-50.3%, illustrating the fact that methods developed for DSR detection are in
general not suitable to detect changes in splicing abundance. We further examined in
more details the programs’ results by gene class. While true positives for all programs
were fairly uniformly distributed across the constituent gene categories, false positives
for MAJIQ, rMATS and Cuffdiff2 were dominated by genes outside of the simulated
gene set, underscoring the difficulty for these programs to effectively distinguish and
filter paralogs and other alignment and assembly artifacts.
We further assessed the methods’ accuracy in quantifying the amount of change
in splicing of individual introns. For the DSR experiment, MntJULiP predictions
51
most closely aligned with the reference annotation (R2 = 0.935, Pearson correlation
coefficient) between predicted and reference dPSI values, compared to 0.879 for
LeafCutter and 0.847 for MAJIQ. For the DSA experiment, MntJULiP had the higher
correlation (0.991 versus 0.848) between predicted and reference log fold change values
of the two methods. Therefore, MntJULiP predicted values are strongly indicative of
the amount of change, and can be used reliably to inform event selection, for instance
to select candidate events for experimental validation.
Figure 3-2. Comparative evaluation of differential splicing methods on 25 control and
25 perturbed simulated RNA-seq data sets: (top) DSR, (middle) DSA, and (bottom)
breakdown of programs’ predictions by the four gene categories (DS, DE, DE-DS and
NONE), and novel (NA), i.e. not in the simulation set.
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3.2.2.2 Performance on real data
We next applied the methods to RNA-seq samples from hippocampus tissue of 24
healthy mice and 20 mice with pilocarpine induced epilepsy, illustrating a typical
RNA-seq experiment. Programs MntJULiP(DSR), LeafCutter, MAJIQ and rMATS
predicted between 700 and 1,137 DSR genes (Figure 3-3, left). While it is not possible
to precisely measure the prediction accuracy in the absence of a ground truth reference,
we deem genes predicted by multiple tools as being more reliable. A majority of DSR
genes (974 out of 1,878) were predicted by two or more tools. Importantly, MntJULiP
had the smallest number and proportion of uniquely predicted genes, 84 (9.7% of
its predictions), compared to 350 genes (35.5%) for rMATS, 367 genes (32.3%) for
LeafCutter and 103 genes (14.7%) for MAJIQ, and therefore potentially reported the
smallest number of putative false positives.
Figure 3-3. Venn diagram of methods’ gene-level predictions on samples from 24 healthy
and 20 epileptic mice.
DSR tests capture only a fraction of the alternative splicing variation in an
experiment. To showcase the potential of MntJULiP to expand upon the classes of
alternative splicing events detected, we assessed the outcomes of MntJULiP’s DSA test.
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Of the 4,187 genes predicted, 485 were also reported by MntJULiP’s DSR test and an
additional 379 by other tools, representing genes with traditional splicing patterns
(Figure 3-3, right). An additional 2,510 genes were determined to be differentially
expressed by the DESeq2 14 method, a category that is captured by the DSA test.
The remaining 813 genes represent a combination of genes with traditional event
patterns that could not have been discovered by other tools and putative complex or
non-conventional splicing events.
Figure 3-4 illustrates some of these cases. The Pyruvate Kinase M 1/2 (Pkm) gene
has two isoforms resulting from the use of mutually exclusive exons (Figure 3-4A). Pkm1
is expressed in the adult stage where it promotes oxidative phosphorylation, whereas
Pkm2 is prevalent during embryogenesis and promotes aerobic glycolysis. Splicing
dysregulation at this gene has been identified as an oncogenic driver and passenger
factor in brain tumors [55]. While the difference in the isofoms’ splicing ratio is low
(0.05) and may have contributed to being missed by other tools, introns flanking both
exons yielded positive MntJULiP DSA tests. Most importantly, MntJULiP can detect
classes of events that cannot be detected by other methods. In one example at the
CWC22 Spliceosome Associated Protein Homolog (Cwc22) gene, the two overlapping
and mutually exclusive introns at the 3’ end of the gene (chr2:77881490-77903814
and chr2:77896578-77903796) do not share an endpoint and therefore could not have
been interrogated by other methods (Figure 3-4B). Similarly, none of the traditional
methods can capture variation that results when one isoform’s intron chain is entirely
subsumed by another, where the ‘extension’ introns do not share endpoints with others.
The ZXD Family Zinc Finger C (Zxdc) gene illustrates this example with its 3’ most
terminal introns. The GENCODE annotation for this gene lists five isoforms, of which
two can be eliminated based on the fact that their unique introns do not appear in
any of the 44 samples. Of the remaining isoforms, two have their intron chains entirely
subsumed by the longest isoform. In Figure 3-4D, the distribution and average fold
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change abundance differs significantly between the shared (average 1.03) and isoform
specific (average 1.45) intron sets, which can only be explained by a difference in
the proportion of splice isoforms in the gene’s output. Lastly, further case analyses
revealed other intriguing scenarios, such as at the Zfp91-Cntf gene locus (Figure 3-4C).
The two genes have in common the only intron in the Ciliary Neurotrophic Factor
(Cntf) gene (chr19:12.764.380-12,765,281), which shows a significant six-fold increase
in abundance in the epileptic mice, whereas all other introns for Zfp91 show a slight
decrease within statistical error. While the event can be at first sight attributed to
the differential splicing of Zfp91, careful observation of the expressed introns reveals
that the sole Zfp91 isoform containing the intron is present at residual levels or not at
all in both conditions. Therefore, the increase in abundance appears to be due to the
change in the expression of Cntf, which owing to the special sharing of gene structure
was missed by DESeq2. Cntf is a survival factor for multiple neuronal cell types, and
an increase in its levels was shown to be involved in attenuating epilepsy-related brain
damage [56, 57].
True accuracy cannot be assessed in analyses on real data. However, to evaluate
robustness and reproducibility in the tools’ predictions as an alternative measure of
performance 9, we divided and analyzed the data into two sets of 10 healthy and
12 epileptic mouse samples. The graphs in Figure 3-5 show the scatterplots of the
estimated difference in percent splicing inclusion (dPSI) between the two replicated
experiments. MntJULiP has the highest correlation between the runs (0.579), followed
closely by MAJIQ (0.577) and LeafCutter (0.460), and therefore its results are the






Figure 3-4. Examples of MntJULiP DSA predictions not identified by other tools (mouse
hippocampus data set), at the (A) Pkm, (B) Cwc22, (C) Cntf-Zfp91 and (D) Zxdc gene
loci. At Zxdc, introns are annotated with the fold change values in the comparison of
healthy and epileptic mice. Note that the genes in (B), (C) and (D) do not have any




Figure 3-5. Reproducibility plots for MntJULiP, LeafCutter and MAJIQ (DSR test)
and MntJULiP (DSA test) on the mouse hippocampus data (A-D). Mouse hippocampus
samples were divided randomly into two sets of 10x12 samples (healthy versus epileptic)
each, and the per intron dPSI values (log2fc) predicted by each program are plotted
between the two comparisons. Number of introns represented: 16,607 for MntJULiP
(DSR), 30,738 for LeafCutter, 93,642 for MAJIQ, and 132,289 for MntJULiP (DSA).
Correlation coefficients for the 4 comparisons are 0.579 for MntJULiP (DSR), 0.460 for
LeafCutter, 0.577 for MAJIQ, and 0.665 for MntJULiP (DSA).
3.2.2.3 Performance on large data sets
To demonstrate the scalability of MntJULiP and its unique capability to perform
simultaneous multi-way comparisons, we applied it to four tissue datasets (frontal
cortex, cortex, cerebellum, and lung; 554 samples total) extracted from the GTEx RNA-
seq collection. We performed pairwise comparisons as well as three-way comparisons
among tissues. In a first experiment comparing the three brain tissues, the multi-way
comparison largely recapitulated the individual pairwise comparisons, detecting 99.0%
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(1,070) of the 1,081 genes and 11 additional genes (Figure 3-6A). The test also revealed
highly similar splicing profiles between cortex and frontal cortex, with only one gene
differentiating the samples. The robustness of the method was confirmed in a second
test, comparing the cortex, cerebellum and lung samples (Figure 3-6C). All but 14, 18
and 21 of the genes reported from the three pairwise comparisons were selected by the
multi-way test, and 37 genes were unique to the three-way comparison, for a 99.3%
(5,324 out of 5,364 predicted genes) recovery rate. Figure 3-7 shows the heatmaps of
PSI values, reiterating these observations. Similar results can be observed for the DSA
test, where the multi-way comparison discovered 97.1% (15,090 out of 15,491) of all
genes detected by pairwise comparisons, and only 36 (0.02%) unique genes among the
15,126 predicted (Figure 3-6D). Importantly, the comparisons highlighted thousands
of differential splicing events that distinguish among the tissues [58]. Experiments
took between 18-44 minutes per comparison on a 24 CPU Intel processor, thereby




Figure 3-6. Multi-way versus all-against-all pairwise comparisons on GTEx tissue samples
- gene sets. (A-B) Venn diagram of gene sets predicted by MntJULiP DSR (DSA) in
comparisons of frontal cortex (105 samples), cortex (121 samples) and cerebellum (132
samples) RNA-seq collections. (C-D) Venn diagram of gene sets predicted by MntJULiP
DSR (DSA) in comparisons of cortex (121 samples), cerebellum (132 samples) and lung




Figure 3-7. Heatmaps of differentially spliced introns from multi-way tissue comparisons.
(A) DSR, frontal cortex-cortex-cerebellum comparison. (B) DSR, cortex-cerebellum-lung
comparison. (C) DSA, frontal cortex-cortex-cerebellum comparison. (D) DSA, cortex-
cerebellum-lung comparison. Note: Introns from genes with > 30 reads across all samples,
with dPSI ≥ 0.2 (for DSR) and q-value < 0.05, were plotted. For DSA, additionally, only
the intron with the largest log 2 fold change was chosen to represent the gene.
3.2.2.4 Application to complex and time-series experiments
All differential splicing methods to date are designed for comparing two conditions,
typically ‘cases’ versus ‘controls’. This simple framework is inadequate and impractical
for scenarios that involve time-series or complex multi-condition experiments, which
seek to determine features that vary across the full range of conditions. As an illustra-
tion, we applied both LeafCutter and MntJULiP to RNA sequencing data from mouse
taste organoids) at seven growth stages [54] (Accession: DRA005238; two samples each
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at days 2D, 4D, 6D, 8D, 10D, 12D and 14D, for a total of 14 samples). LeafCutter
predicted DSR events in 889 genes and MntJULiP in 3,285 genes when combining the
results from all-against-all pairwise analyses. By comparison, MntJULiP’s multi-way
test predicted 204 differentially spliced genes across all conditions. While true accuracy
cannot be measured, we deem features (genes) reported by multiple comparisons to
have higher confidence than those predicted in a single comparison, on the basis that
features that are differentiated between two stages will likely show variation in other
comparisons involving one of the original conditions.
Figure 3-8. Assessment of program predicted features for the time-series taste organoid
data set, based on the assumption of continuity of feature space. The distribution of
program-predicted features by number of comparisons is shown for three methods: i) union
of MntJULiP predicted features from all (21 total) pairwise comparisons, ii) MntJULiP
multi-way predicted features, and iii) union of LeafCutter predicted features, from all
pairwise comparisons (21 total). For MntJULiP multi-way predictions, features were traced
back to the pairwise comparisons in which they were reported (from i).
As Figure 3-8 indicates, the distribution of genes according to the number of
comparisons in which they are reported is very similar for the LeafCutter and Mn-
tJULiP pairwise protocols, with 31-36% of the genes found in only one comparison,
pointing to potentially large numbers of false positives. In contrast, the distribution
for MntJULiP multi-way predicted genes follows a Bell curve distribution with the
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mode at 8 comparisons, which provides a more realistic reflection of the experiment.
Therefore, the multi-way comparison more accurately identified differences in splicing
across the experimental range.
To further examine the landscape of alternative splicing variation during organoid
differentiation, we generated heatmaps of the introns discovered with the MntJULiP
all-pairwise and the MntJULiP multi-way comparison methods (Figure 3-9). Introns’
PSI values show small variation in splicing between consecutive stages, but clear
distinguishing characteristics when comparing across all experimental timepoints. In
particular, features detected by the multi-way comparison clearly distinguish between
the organoid growth stages, with a significant inflexion point between early (days
2D-6D) and late development and differentiation into taste cells (days 8D-14D), and
facilitate more accurate clustering of samples. Interestingly, the visualizations point
to distinguishing features separating stage 2D from the other non-differentiated stages,
and the separation becomes even more apparent in the DSA visualizations (Figure 3-
9B). The two visualizations provide complementary and overlapping views of the
changes in the global transcriptome, with DSA reflecting changes in the expression level
of features, and DSR reflecting changes in the relative contribution of isoforms. We
note here that, from a technical standpoint, the DSR and DSA maps reflect different
data types and characteristics; while the PSI values in the DSR maps are restricted
to the [0,1] interval and are more limited in their variability, the feature expression
levels in the DSA displays potentially range over 4-5 orders of magnitude (4-5 fold in
logistic conversion) and exhibit over-dispersion, and therefore may reflect more clearly
the changes in the global transcriptome, and be better suited to highlighting more
subtle changes. (These observations have led us to develop the comprehensive and
flexible visualization tools in section 3.3.) Importantly, these graphical representations
highlight the ability of MntJULiP to detect even mild differences between conditions.
We also note the ability of MntJULiP to work with very small numbers of samples
62
per condition, as low as two samples per organoid stage.
(A) (B)
Figure 3-9. Heatmaps of differentially spliced features (introns) in the taste organoid data
set. (A) MntJULiP DSR, features discovered via multi-way comparison; (B) MntJULiP
DSA-predicted features. Heatmaps show PSI (A) or expression log fold change (B) values.
Features were filtered at p-value<0.05 and dPSI>=0.2 (for DSR). Grouping was performed
using weighted hierarchical clustering with the Bray-Curtis metric.
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3.3 Jutils: A visualization toolkit for differential
alternative splicing events
While multiple methods have been developed to determine differential splicing patterns
from RNA-seq data (LeafCutter, MAJIQ, rMATS, MntJULiP [33, 34, 38, 59], there
is a scarcity of tools to present the results to the user in a way that is intuitive and
easy to explore. Moreover, most visualization tools are designed for a particular
differential splicing method, such as rmats2sashimiplot (https://github.com/Xinglab/
rmats2sashimiplot) and LeafViz (https://leafcutter.shinyapps.io/leafviz/), and are not
adapted for general use. To fill this gap, we developed Jutils, a toolkit for visualizing
alternative splicing differences that can be used across methods.
3.3.1 System design
Jutils works with the output of a differential splicing tool, converting it into a unified
data file that contains the information necessary for the visualizations. (Additional
information, such as the BAM files, can be optionally provided.) Metadata about
experiment design, such as the condition associated with each sample, can be provided
in a specification file. Jutils then extracts events to include in the visualizations based
on user specified criteria. Lastly, it generates one of three types of visualizations:
heatmap, sashimi plot, and Venn diagram. Details of each component are provided
below.
3.3.1.1 The unified file format
Jutils uses an intermediate Tab Separated Values (TSV) file format to collect event
information generated by a differential splicing program, which it then uses to create
visualizations. Jutils has built-in output conversion modules for several analysis
programs, including LeafCutter, MAJIQ, MntJULiP, and rMATS, and users can
develop their own conversion scripts for other programs of interest.
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The TSV file has 14 columns containing, in order: gene name, group id, feature id,
feature type (e.g., intron, event skipping), feature label (derived from the chromosomal
location), strand, p-value, q-value, dPSI (difference in Percent Splice In values), read
count 1, read count 2, and PSI values per sample, estimated PSI per condition. The
default feature for Jutils is introns, but the program can represent more complex events
such as those reported by rMATS, for instance, exon inclusion and exon exclusion
constituted as a single exon-skipping event. Programs may further aggregate features
into groups, for instance LeafCutter and MntJULiP group introns that share a splice
junction. Jutils supports identifiers and operations on individual features as well as
groups. Read count 1, read count 2, and PSI represent vectors of per sample values.
Read counts 1 and 2 correspond to the paired splice forms in a complex feature (e.g.,
exon skipping), whereas for simple features (e.g., introns) read count 2 is marked with
‘.’.
3.3.1.2 Heatmaps
Jutils generates heatmaps of differential splicing events represented in the TSV file. A
metadata file contains the classification of each sample. Jutils generates heatmaps of
PSI values, either Z-score normalized or absolute values (Figure 3-10A). The software
allows clustering by rows (events) and columns (samples), using different distance
metrics and clustering methods. By default, the ‘cityblock’ (Manhattan distance)
metric with the ‘weighted’; (weighted pair group with arithmetic mean) method is
used. Events can be filtered at run time based on quality and confidence measures
such as p-value, q-value and dPSI, and the user may choose to visualize all relevant
features or select a representative feature per group or per gene. Lastly, while Jutils is
intended to work primarily with the output of differential splicing tools, it can also be
used to display the features with the highest variance (option ‘–unsupervised’).
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3.3.1.3 Sashimi plots
Sashimi plots have been previously introduced to visually represent differences in
splicing. A traditional sashimi plot shows raw RNA-seq densities along with exons
and junctions for multiple samples. The Jutils sashimi visualization utilizes a modified
version of the ggsashimi package [60] to display graphical representations of intron
read counts within a specified genomic region, intron, or intron group (Figure 3-10B).
By default, Jutils provides a lightweight repre-sentation based solely on the intron read
counts provided in the TSV file, without the flanking exon read depth information.
When alignment files are also provided, Jutils extracts alignments from the BAM files
and provides full sashimi representations reflecting the accurate exonic coverage.
3.3.1.4 Venn diagrams
Methods for differential splicing detection employ a variety of models for features
and objective functions. Therefore, it becomes desirable to compare the outputs of
different programs to obtain a complete view of the predicted differential splicing and
to gauge support from multiple tools. Jutils provides a Venn diagram visualization of
the gene sets predicted by multiple programs (Figure 3-10C), along with a text file




Figure 3-10. Jutils visualization of differential splicing events from the comparison of hip-
pocampus samples of 12 healthy and 10 epileptic mice (GenBank ProjectID: PRJEB18790).
(A) Heatmaps of absolute (left) and Z-score normalized (right) PSI values generated with
MntJULiP shown, respectively, at the intron and group level. Left: darker red indicates
PSI values closer to 1; Right: blue colors mark values lower than the row average, and
red ones values higher than the row average. (B) Sashimi plot of events at the Dync1i2




Detecting differences in splicing patterns between cellular conditions is a critical task.
Multiple methods have been developed that differ in their target features, objective
function, and employed techniques, which makes selecting a tool and comparing
the results across methods daunting [50]. To answer the need for highly accurate
methods combined with a systematic approach to problem definition, we developed
MntJULiP. MntJULiP provides a comprehensive view of alternative splicing variation,
by representing it at the most granular level (intron) and by implementing two objective
functions, aimed at determining differences in the absolute and relative (ratios) intron
splicing levels. In comparisons on simulated and real data, we demonstrated that
MntJULiP identifies more alternative splicing variation and more classes of variation
than other tools, and across a spectrum of experimental conditions, dataset sizes and
degrees of variation.
Traditionally, differential analyses have targeted gene expression changes that
could lead to the discovery of causative or marker genes for diseases or other cellular
conditions. The advent of deep RNA sequencing has made it possible to uncover
finer grained changes in the gene’s output, at the level of the transcripts that it
expresses. Both changes in the expression level of a given transcript, often referred to
as isoform specific regulation, and changes in the relative proportion of splice isoforms
of a gene, lead to biological and phenotypic changes. Therefore, it is important to
design tools that address each of these problems. The differential splicing abundance
(DSA) and differential splicing ratio (DSR) define the two problems in computational
terms, and methods for differential splicing detection have adopted either of these
models. However, there has been no software that implements them both, in a unified
framework, to allow comprehensive discovery and the unbiased comparison of their
results. Our DSA and DSR models, implemented in MntJULiP using a unified bayesian
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architecture and feature selection filters, are individually powerful, and taken together
provide a comprehensive view of transcriptomic variation.
MntJULiP introduces several technical innovations, including its zero-inflated
negative binomial and multinomial Dirichlet models to account for low count genes
and splice junctions, and the mixture distributions that allow for modeling multiple
conditions, thus facilitating multi-way differential analyses. The ability to perform
multi-way comparisons, in both its DSA and DSR modes, is unique to MntJULiP, and
is desirable when characterizing complex time series or multi-condition experiments,
to identify a global set of features that distinguish among subgroups or stages.
MntJULiP also has limitations. While it benefits from being able to extract the
splicing event information directly from the RNA-seq read alignments, without the
need for reference gene annotations, MntJULiP relies on the splice junction information
gathered from the sequence alignments. Therefore, the performance of MntJULiP
largely depends on the reliability of the alignments. Spliced alignment is a highly
complex computational problem, with heuristic solutions that may not accurately
capture all biological patterns, for instance non-canonical splice sites or introns flanking
very short exons. Further, sequencing errors as well as genuine differences between
the RNA-seq sample and the reference genome can lead to difficulty in mapping
to the correct location, if multiple potential matches exist. Furthermore, aligners
could introduce biases to the alignments. For example, sequence-specific bias due
to GC-content and dinucleotide frequencies and motif content in hexamer primer
regions could reduce the ability of MntJULiP and other alternative splicing analysis
tools to accurately quantify the events. Moreover, the existing aligners that utilize a
standard reference genome as a template sometimes have difficulty in mapping reads
that carry rare genomic variants, which can lead to allelic ratio biases and could
hamper MntJULiP’s ability to accurately assess the differences in splicing patterns.
Lastly, to complement our effort with designing differential splicing tools, and to
69
meet the needs for intuitive and easy to use visual representations, we also developed
Jutils, to make the results accessible and easy to interpret by the users. Jutils is
a lightweight toolkit for visualizing differential alternative splicing between cellular
conditions. It can be used automatically with the popular differential splicing analysis
tools LeafCutter, MAJIQ, MntJULiP, and rMATS, and can be easily adapted to any
other program, and thus represents a useful and practical tool to explore the landscape
of alternative splicing.
Overall, our tools are highly efficient and scalable, providing an effective platform
for comprehensive differential splicing analyses of RNA sequencing data from a wide
range of experiments and data collections.
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Chapter 4
A Deep Learning (DL) splicing
model
As we discussed in the previous Chapters, alternative splicing of pre-mRNA represents
an important regulatory mechanism that contributes to protein diversity in the cellular
environment. However, its mechanisms are still incompletely understood. While a
plethora of regulatory cis- and trans-factors are known to interact to determine the
splice site selection and alternative splicing outcome, the mechanisms remain to be
revealed. Splicing signals can be very complex, and most alternative splicing outcomes
involve the competition among candidate splice sites. Therefore, splicing patterns can
be controlled by any mechanism that alters the relative rates of splice site recognition.
In this chapter, we focus on the RNA sequences around the splice sites, and build a
computational model aimed at revealing the splicing regulation. More specifically, we
describe a probabilistic deep learning model to predict and quantify alternative splicing
events from the information on cis-regulatory sequence elements and trans-splicing
factors in different tissues.
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4.1 Background
4.1.1 Regulation of alternative splicing
In the pre-mRNA splicing process, relatively small exons (∼100 nt) are generally ligated
while much longer introns (>1000 nt) are excised. Pre-mRNA splicing is carried out
by spliceosome, a large complex consisting of several small nuclear ribonucleoproteins
(snRNPs) and auxiliary protein factors. The spliceosome removes introns from a
transcribed pre-mRNA, a type of primary transcript. A spliceosome is either recruited
or assembled at the correct 5’ splice site (donor) and 3’ splice site (acceptor), in part
through recognition of conserved sequences spanning the intron-exon junctions [61]. A
canonical splice site contains the dinucleotides ‘GU’ and ‘AG’ at the 5’ end and 3’ end
of an intron, respectively, and a branch point containing a conserved ‘A’ upstream
of the 3’ end in the intron. The snRNPs recognize these splicing signals, bind to
the pre-mRNA sequence and help assemble the spliceosome. The splice site signals
are typically only a few nucleotides long and very common in pre-mRNA sequences,
resulting in a large number of candidate splice sites. In reality, however, only a
handful of splice sites are recognized by the spliceosome, and the splicing process
is conservative and highly regulated, especially for the protein coding genes. These
suggest the existence of a global and local regulated machinery that precisely controls
the recognition of splice sites.
While splice site consensus sequences are necessary for splicing, starting with
the formation of the spliceosome, they are not sufficient in many eukaryotic systems.
Changes in splice site choice (alternative splicing) arise from combinatorial interactions
among cis- and trans-regulatory factors mediated by the spliceosome. Outside of
the core splice signals, the bulk of the information required for splicing is thought
to be contained in exonic and intronic cis-regulatory elements. Those cis-regulatory
elements function by recruiting sequence-specific RNA-binding proteins that either
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activate or repress the use of adjacent splice sites [2]. The RNA sequences that act
positively to stimulate spliceosome assembly are called splicing enhancers. Conversely,
the RNA sequences that act negatively to block the spliceosome assembly and certain
splicing choices are called splicing silencers or repressors.
Besides their mode of action, the location of cis-regulatory sequences is also
important. Exons often contain enhancer or silencer elements that affect their ability
to be spliced. There are many exonic splicing enhancers (ESEs) and most of them
interact with a family of splicing regulatory proteins known as SR proteins. The SR
proteins form a group of highly conserved proteins that are required for constitutive
splicing and also influence alternative splicing regulation. SR proteins bound to ESEs
can promote U2AF recruitment to the polypyrimidine tract and activate an adjacent
3’ splice site[62–64] (Figure 4-1). Moreover, other non-SR proteins may also interact
with the ESEs to regulate splicing. In one example, proteins YB-1 and p72 are found
to mediate an AC-rich splicing enhancer at the human CD44 gene [65, 66]. To contrast
the positive action of exonic splicing enhancers, exonic splicing silencers (ESSs) have
also been identified. The best characterized of these are bound by the hnRNP proteins
[67]. As an example, the hnRNP A1 protein can bind to an ESS to create a zone of
the RNA where spliceosome assembly is repressed (Figure 4-2A).
Many splicing regulatory sequences are present in introns rather than exons. Bind-
ing sites for regulators are often found within the polypyrimidine tract or immediately
adjacent to the branch point or the 5’ splice site. Similarly to exonic regulation,
positive- and negative-acting sequences make up intronic splicing enhancers and si-
lencers, respectively (ISEs and ISSs). In the example in Figure 4-2B, the hnRNP A1
protein binds to an ISS adjacent to the branch point to block U2 snRNP binding to
the branch point. Further, the uridine-rich sequence immediately downstream of the
5’ splice sites was found to bind the protein TIA-1 (Figure 4-1), and TIA-1 stimulates
U1 snRNP binding to 5’ splice sites [68].
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Therefore, alternative splicing is regulated by the complex interactions of cis-
acting regulatory sequences, which can act to enhance or suppress splicing, and the
trans-acting proteins that bind to them.
Figure 4-1. Mechanisms of splicing ac-
tivation with SR proteins as splicing acti-
vators (image from [4]).
Figure 4-2. Models for splicing repres-
sion by hnRNP A1 (image from [4]).
4.1.2 RNA binding proteins
RNA binding proteins (RBPs) are a specialized type of proteins that can bind to
RNA sequences and potentially play a role in the regulation of gene expression. Each
alternative splicing event is controlled by multiple RBPs, the combined action of which
creates a distribution of alternatively spliced products in a given cell type. Therefore,
the interpretation of regulatory information on a given RNA target is exceedingly
dependent on the cell type. Current estimates are that more than 1,500 proteins have
the capacity to bind the human RNA sequences, and as many as 690 proteins are
mRNA-binding [69]. Some RBPs are key regulators of post-transcriptional regulation.
The functions of RBPs are largely dependent on the binding location, either activating
or repressing the splice site choice.
As an example of RBPs, SR proteins are a conserved family of proteins involved
in RNA splicing. An SR protein has one or several RNA recognition domains (RRM
domains) to bind the RNA sequence, and an arginine and serine residues domain (SR
domains) to interact with other proteins. SR proteins promote the binding of U1
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snRNP, and U2AF auxiliary factor, and stimulate the formation of the spliceosome.
Therefore, SR proteins contribute to splice site recognition by directing the splicing
machinery to different splice sites under different circumstances.
Another class of important splicing factors is that of hnRNP proteins. hnRNP
proteins are less conserved compared to the SR proteins. hnRNP proteins contain the
RRM domains but lack an RS domain. hnRNP proteins can bind to RNA sequences
but are unable to interact and recruit the snRNPs. Therefore, they play a role in
repressing splicing by directly antagonizing the recognition of splice sites, blocking
the SR proteins’ binding to splicing enhancers, or hindering communication between
splicing factors.
The major families of RBPs contain canonical RNA-binding protein domains, such
as the RNA-recognition motif (RRM), CCCH zing finger, K homology (KH) and cold
shock domain (CSD). Recently developed technologies such as crosslinking of RNA
to proteins followed by sequencing (CLIP-seq) [70], SELEX [71], RNAcompete [72],
RNA Bind-n-Seq (RNBS) [73] have been used to determine the binding locations and
specificities of a growing number of RBPs [74–76].
4.1.3 Sequence motifs
Deciphering the mechanisms behind splice site choice requires a comprehensive list
of splicing regulatory RNA-binding proteins (RBPs) and their cis-acting binding
sites. Recent technologies mentioned above (CLIP-seq, RNAcompete, RBNS) can
help identify the binding preferences of RBP, in vitro or in vivo.
To represent RBP binding affinities to an RNA sequence computationally, so called
Position Weight Matrices (PWMs), as designed for transcription factor binding sites,
have been adopted [77]. A typical PWM is a 4 × W matrix in which position (j, w)
gives the probability of observing the nucleotide j at position w of a motif of length
W. PWMs are most often derived from collections of known binding sites for a given
75
protein, or through computational methods applying pattern discovery algorithms to
functional genomics data.
4.1.4 Other splicing regulatory mechanisms
SR proteins and hnRNP proteins can explain a large variety of splicing decisions, but
the control mechanisms of alternative splicing are diverse and complex. In one scenario,
binding of SR proteins to the ESEs can antagonize the activity of hnRNP proteins
recognizing ESS elements [78]. Therefore, the relative abundance of SR proteins and
hnRNP proteins could be important in regulating the patterns of alternative splicing
in a tissue-specific or developmentally regulated manner [79].
Although a single critical factor (the binding proteins) has not been shown to
determine the tissue specificity of splicing in any system, the expression of some
splicing regulatory proteins is restricted to certain cells. NOVA-1, a neuron-specific
RNA binding protein regulates neuron-specific alternative splicing (Figure 4-3A)
and is essential for neuronal viability [80]. CELF proteins bound to muscle-specific
enhancers (MSE) in the cardiac troponin-T gene (cTNT) can promote inclusion of
the developmentally regulated exon [81].
Different binding regions and concentration of a factor may also alter its functional
activity. SR proteins bound to an intronic sequence near a branch point would block
the use of this 3’ splice site and shift splicing to an adjacent site [82]. Excess of hnRNP
A/B proteins has the opposite effect, promoting the selection of intron-distal 5’ splice
sites.
4.1.5 Mutations affect alternative splicing
Point mutations, such as base substitutions, in genes may alter the target sequences by
changing a codon for one amino acid into one coding for another or into a premature
termination codon (PTC). Additionally, point mutations could change the sequence
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around the splice site, and therefore have a more subtle influence on alternative
splicing. Synonymous single-nucleotide polymorphisms (SNPs) located in coding
regions can disrupt (or create) exonic splicing enhancers and silencers [83, 84]. The
mutations located in non-coding regions, such as those affecting 5’ and 3’ splice sites,
branch sites or polyadenylation signals, can also alter the splicing pattern [85, 86].
Other types of mutations, for example, nonsense and missense mutations as well
as exonic deletions or insertions, can affect alternative splicing in similar ways [87].
Mutations, as a consequence, can lead to the appearance of truncated proteins or to
the lack of the correct gene product, and are frequently the cause of hereditary disease
(Figure 4-3B). However, the incomplete understanding of the mechanisms for splice
site choice hampers our ability to accurately predict the effects of mutations and to
identify splice altering variants around the splice sites.
(A) Splicing regulatory proteins regulate
neuronal cell differentiation through alter-
native splicing (image from [55]).
(B) Mutations lead to abnormal splicing
patterns and result in tumor proteins.
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4.1.6 The ‘splicing code’
To understand the complexity of pre-mRNA splicing, we must study how changes in
splice site choice come about. For several decades now, the molecular components
have been characterized and evidence for protein-nucleic acid interactions have been
accumulating. A long list of splicing regulatory cis-elements have already been
identified, and their associated trans-acting factors determined. Hence, it has become
possible to assemble the available information into a computational framework to
predict the splicing patterns of different cells and developmental stages. A long-term
goal in the area of alternative splicing is to determine a set of rules (or code) for
splicing [88]. Such a code would also be instrumental in predicting the consequence
of mutations on splicing. It would be of great value not only to molecular biologists
and geneticists, to enable better understanding of splicing events and the effect of
mutations on mRNA splicing, but also to clinical researchers, to design new therapeutic
approaches based on splicing interference [89].
Efforts to understand the splicing code have previously entailed statistical or
machine learning methods that extensively integrate combinations of diverse RNA
features. Barash et al. [90] adopted hundreds of RNA features to predict tissue-
dependent changes in alternative splicing for thousands of exons. Zhang et al. [91]
used Bayesian networks to probabilistically model diverse datasets and predict the
target networks of specific regulators. With the advance of next-generation sequencing
technologies, new tools have been designed to predict the splicing pattern largely
based on the DNA/pre-mRNA sequences. Xiong et al. [92] and Zijun et al. [93]
used deep learning to derive a computational model that takes DNA sequences
as input and applies general rules to predict splicing in human tissues. Given a
variant, Xiong’s model computes a score that predicts how much the variant disrupts
splicing. Jaganathan et al. [94] developed a deep residual neural network (spliceAI)
to predict cryptic splice sites and the effects of mutations on splice site usage, using
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pre-mRNA sequences as inputs. Unlike other computational models, this model works
on long-range primary genomic sequences (>5k bp), and therefore can include multiple
candidate splice sites and nonfunctional regions into consideration.
4.2 A Deep Learning (DL) splicing model
In this Chapter, we describe a novel probabilistic deep learning splicing model, using
as input sequence elements and trained on intron-supporting read counts extracted
from RNA-seq data. The model predicts intron splicing ratios from cis-acting sequence
elements around the splice sites and the trans-acting splicing factors, represented by
learned motifs.
4.2.1 Model design
Our deep learning splicing model consists of a sequence of individual networks that
learn increasingly deeper hidden relationships among the data. The input to the model
are sequences surrounding the splice sites of introns along with tissue information, in
combination with splicing ratio derived from RNA-seq data using MntJULiP, and the
output is, for a given intron, its splicing ratio in a specified tissue.
4.2.1.1 The learning model
Over-dispersion is a known characteristic of RNA-seq data and needs to be accounted
for in modeling count data. To model over-dispersion, similarly to our approach
implemented in MntJULiP, we use a Dirichlet-Multinomial distribution. Let x =
(x1, x2, . . . , xK) be the counts of sequencing reads mapped to the K alternative splice
junctions (introns) in a ‘bunch’ that shares a splice site. Then, we assume x follows a
Dirichlet-Multinomial distribution with unknown parameter α = (α1, α2, . . . , αK):
x1, x2, . . . , xK ∼ Dirichlet−Multinomial(α1, α2, . . . , αK)
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Unlike MntJULiP, which estimates the parameter α for each individual ‘bunch’ of
introns using a Bayesian model, here we design a neural network that takes as input of
sequence elements, learns hidden relatoinships, and reports, as the output, the α for
the Dirichlet-Multinomial distribution. More specifically, we propose a probabilistic
deep learning model (PDL) to predict the introns’ splicing ratios given the sequence
elements around the splice sites (Figure 4-4). The PDL model consists of several
convolutional neural networks (CNNs) to extract features from the sequence elements
around the splice sites, a fully connected layer to convert the feature representations
to scores for different tissue types, and a Dirichlet-Multinomial layer that learns and
predicts the splicing ratios as PSI values. Each individual network component is either
a specifically designed convolutional neural network, a fully connected network, or
a probabilistic module to extract information from its input. The details of each
component are described below.
Figure 4-4. The architecture of the probabilistic deep learning splicing model.
4.2.1.2 The RBP-PWM CNN layer
A key functionality of convolutional neural network (CNN) is to filter and summarize
latent features from its inputs. The CNN functions by multiplying the CNN weight
matrix (called filter) with the input matrix to generate one value to summarize the
input. This process is very similar to how a position weight matrix (PWM) function.
For the first CNN layer, we optionally initialize the CNN filter by the RBP PWMs
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collected from the public RBP databases. Given the sequence inputs, the first CNN
layer outputs the scores representing the binding affinity of RBPs to particular sequence
positions.
4.2.1.3 The Deep CNN layer
Followed by the RBP-PWM CNN layer is a deep CNN layer. The purpose of this
layer is to extract and combine the latent information from the RBP PWM score
vectors, forming a deep representation of the sequence elements that can be used as a
key latent feature for a splice junction (intron).
4.2.1.4 The Scoring layer
Further, we design a fully connected layer, taking as input the sequence representation,
summarizing it, and generating scores to represent a splice junction. For example, for
a model with 7 tissues, the model will generate 7 scores to represent a splice junction
under the 7 different tissues.
4.2.1.5 The Dirichlet-Multinomial layer
The scores generated by the scoring layer can be used as the hyper parameter α for
our Dirichlet-Multinomial distribution. In the training step, the Dirichlet-Multinomial
layer receives the inputs of α, sampling the probabilities p = p1, p2, . . . , pK that will
be used in the loss function. Following training, the Dirichlet-Multinomial layer can
predict the splicing ratio for each intron, and for each tissue.
4.2.1.6 The loss function
For training, the model requires two types of inputs: the first is the sequence elements
s = (s1, s2, . . . , sK) of the candidate splice junctions, and the second is the RNA
sequence read counts x = (x1, x2, . . . , xK) that mapped to the splice junctions. A
log likelihood estimate is used to train the model. In detail, fnn(s; θ) is the neural
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network (with parameters θ), receiving the sequence elements s and generating as
output the parameter α of the Dirichlet-Multinomial distribution. The probability
mass function of the K-categories Multinomial distribution of N trials (sum of read







Where the probabilities p follow a prior Dirichlet distribution, and the probability







Where Γ(x) is the gamma function and A = ∑︁Ki=1 αi. Putting together the two
functions, the probability mass function of the Dirichlet Multinomial distribution is
derived:







Γ (αk + xk)
Γ (αk)
Removing terms only containing N and x, and taking the logarithm, we have the
loss function with respect to the parameters θ,
L(θ; s, x) = logΓ(A) − logΓ(A+N)
K∑︂
k=1
(logΓ(fnn(sk; θ) + xk) − logΓ(fnn(sk; θ))
After defining the loss function, the PDL model can be trained with the Adam
optimization algorithm [95].
4.2.1.7 Input and Output
To allow investigating how the sequence elements and associated trans-splicing factors
affect the selection of introns, the model implements three types of inputs. The
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first input is the RNA sequence (Figure 4-5). The RNA sequence around the splice
site contains the exonic splicing enhancers (ESEs), exonic splicing silencers (ESSs),
intronic splicing enhancers (ISEs), and intronic splicing silencers (ISSs), which are
the binding motifs for RBPs. The second type of input consists of the splice junction
read counts to represent the ‘expression’ level of an intron. The third type of input
is the RBP RNA recognition motif (RRM), the RNA binding domain of the RBP.
For this type of input, we downloaded position weight matrices (PWMs) of RBPs
from online databases, such as the ATtRACT database [96]). Due to the structure
similarity between PWMs and filters in the neural net, we can initialize and fix the
neural filters in the RBP-PWM CNN layer by the downloaded PWMs (Figure 4-4).
In this way, we incorporate the biological knowledge in the RNA binding proteins
and their associated motifs into the PDL model, which would potentially improve the
model performance.
To investigate the differential usage of the introns, we group introns into ‘bunches’
by their sharing splice sites, as described in Chapter 3. Given a set of introns that
share either a 5’ splice site or a 3’ splice site, and I1, I2, . . . , In their (expected) read
counts, we define the splicing ratio Ψj for intron j as: Ψj = Ij/
∑︁n
k=1 Ik. It is easy to
see that Ψj ∈ [0, 1], and can be viewed as a probability. See Figure 4-6 for a simple
example of Ψ value.
To implement the model, we used an engineering solution, feeding into the PDL
model batch inputs grouped by the intron ‘bunches’. For example, assume we have
256 bunches, where each bunch contains 2 introns that share a splice site. We merge
the one-hot encoding inputs (4 × 200 matrix) of the 2 introns, forming a 2 × 4 × 200
tensor. We group those 2 × 4 × 200 tensors into a batch, forming a 256 × 2 × 4 × 200
tensor that we feed into the PDL model.
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Figure 4-5. Two example sequences of 14 bp each, centered by the left and right splice
sites of the intron. These two sequences are concatenated together to form a sequence
element to describe the intron.
Figure 4-6. An example of a mutually exclusive splicing event. Let I1 be the (expected)
read counts of intron 1, I2 be the (expected) read counts of intron2, then Ψ1 = I1/(I1 +I2)
and Ψ2 = I2/(I1 + I2).
4.2.1.8 The sequence element and one-hot encoding
200 bp sequences are extracted for each splice site for training, and the ‘ATCG’
sequences are converted to a one-hot 4 × 200 encoding matrix for each splice site. An
intron contains two splice sites, hence the input is a 4 × 400 matrix (Figure 4-7).
Figure 4-7. An example of the one-hot encoding of a given sequence.
4.2.2 Experiment setup and results
We evaluated our model for its ability to learn splicing information, in several ways.
First, we tested the program to predict intron splicing ratios learned from RNA-seq
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data in 7 tissues. Second, we evaluated the ability of the model to learn sequence
features that are important for splicing, such as binding sites of core and auxiliary
splicing regulatory proteins. Third, we assessed the potential to predict the impact of
sequence variants (mutations) on splicing using an in silico mutagenesis experiment.
4.2.2.1 Sequences and reference splice junctions
We obtained 144 RNA-seq samples from 7 tissues (Table 4-I) from the NIH Roadmap
Epigenomics Mapping Consortium [97]. After downloading the FASTQ files, we
aligned the reads to the reference genome (hg38) with STAR and extracted the splice
junction read counts from the alignments with the tool junc [18]. To build a reliable
reference set to train the deep learning model, we filtered out splice junctions with low
read counts (i.e., average read count ≤ 4 across all 144 samples). We considered the










Table 4-I. The 7 tissues.
Next, we extracted the splice sites in protein coding genes from the GENCODE
annotation v.37 [41], and used them to group the introns (splice junctions) into
‘bunches’ as defined earlier. Hence, two or more introns that share an annotated splice
site were kept (including the novel introns that were not in the reference annotation).
We did not consider the novel splice sites present in the data, because they may be




We build two PDL models for training and evaluation, which largely share the same
architecture, but with a key difference. For the first model, herein named DNN1, we
initialize the filters of the RBP PWMs CNN Layer by RBP PWMs downloaded from
the ATtRACT database [96]. A quality value of 0.1 was used to filter the PWMs, and
1041 PWMs for 151 human RBPs were selected. For the second model, named DNN2,
we randomly initialized 1024 (4 × 1024) filters for the RBP PWMs CNN Layer.
4.2.2.3 Training and testing data
We split the data into a training set and a test set. We randomly selected 10% of the
non-homologous protein coding genes as testing genes, and extracted the alternative
splice sites and introns from these genes for testing; all the remaining alternative splice
sites and introns were used for training. In our case, 51,165 splice sites were used for
training, and 4,931 splice sites from 1,079 genes were used for testing.
4.2.2.4 Performance in predicting splicing ratios
Building a ground truth splicing ratio data set for evaluation is a daunting task,
as experimentally validated data are not available at genome-wide scale. Instead,
we used MntJULiP on the testing splice sites and introns to generate the splicing
ratios to be used as reference. Note that an exact splicing ratio match between the
PDL and MntJULiP is impossible, because MntJULiP and PDL are two different
types of machine learning models and receive different inputs (read counts versus
sequence elements). Therefore, we adopt the evaluation metrics previously proposed
in the literature that classify the splicing ratio Ψ into low (0 ≤ Ψ < 0.33), median
(0.33 ≤ Ψ < 0.66) and high (0.66 ≤ Ψ ≤ 1). With this convention, we define a
true positive (TP) if the predictions of MntJULiP and PDL for a given intron lie
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within the same category, and otherwise we define a false positive (FP). The AUC
metric is then used to measure the performance, and the statistical results are listed
in Table 4-II. Surprisingly, DNN2’s performance appears better than DNN1’s, despite
the fact that DNN1 adopted the referenced RBP PWMs as additional information in
its RBP PWMs CNN Layer. We set to investigate this observation in the following
sections.
Tissue Method Low Medium High
Adipose DNN1 0.6940 0.5375 0.7013DNN2 0.6968 0.5506 0.7043
Esophagus DNN1 0.6917 0.5263 0.6998DNN2 0.6959 0.5388 0.7043
Lung DNN1 0.6879 0.5286 0.6971DNN2 0.6936 0.5598 0.7010
Ovary DNN1 0.6825 0.5593 0.6896DNN2 0.6884 0.5358 0.6963
Pancreas DNN1 0.6906 0.5243 0.6991DNN2 0.6942 0.5414 0.7020
Gastric DNN1 0.7160 0.5609 0.7185DNN2 0.7285 0.6112 0.7305
Spleen DNN1 0.7001 0.4901 0.7104DNN2 0.7090 0.5935 0.7171
Table 4-II. Comparison of the two models AUC performance on RoadMap Epigenomics
data.
4.2.2.5 The model learns RBP binding motifs
We hypothesize that DNN2 automatically discovers known and novel sequence motifs.
To evaluate this hypothesis, we extracted the 1024 filters from DNN2’s RBP PWMs
CNN Layer. We view the filters as PWMs and search for them in the CISBP-RNA
database [72] and the RNAcompete RBP database [72]. We then used the TomTom
motif comparison tool [98], with a q-value threshold of 0.1 to filter the results. We
found that our PWMs matched 62 human RBP PWMs in the RNAcompete database
(102 in total), and 51 PWMs in CISBP-RNA database (97 in total). Further, the
predicted motifs matched annotated motifs for important RBPs, such as the SR
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Figure 4-8. Model predicted motifs versus the annotated motifs of key splicing factors.
Top left: SRSF1, top right: SRSF2, bottom left: hnRNPA2B1, bottom right: U2AF2.
protein family, the hnRNP protein family, and key splicing auxiliary factors (e.g.,
U2AF) (Figure 4-8). Hence, DNN2 can be used to model the sequence characteristics
of the core splicing motifs, and can potentially characterize exonic and intronic splicing
enhancers and silencers.
4.2.2.6 Performance robustness with different test data
Next, we tested whether the performance of the PDL models generalize to RNA-seq
data from a different experiment. We obtained RNA-seq data from 7 human tissues
(adipose, esophagus, lung, ovary, pancreas, stomach and spleen) from the GTEx
project, with 5 samples for each tissue, where ‘stomach’ matches the ‘gastric’ in
RoadMap project. As before, we aligned the reads to the hg38 human genome with
STAR, and used the tool junc to calculate the splice junction read counts. Using the
same test genes, we extracted the alternative splice sites and their associated introns,
and predicted the splicing ratios for specific tissues with DNN1, DNN2, and with
MntJULiP as reference. The AUC results are reported in Table 4-III.
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Tissue Method Low Medium High
Adipose DNN1 0.6878 0.5442 0.6958DNN2 0.6944 0.5442 0.7031
Esophagus DNN1 0.6827 0.5559 0.6883DNN2 0.6975 0.5460 0.7045
Lung DNN1 0.6846 0.5188 0.6950DNN2 0.6987 0.5460 0.7082
Ovary DNN1 0.6831 0.5398 0.6928DNN2 0.6964 0.5426 0.7059
Pancreas DNN1 0.6827 0.5205 0.6913DNN2 0.6982 0.5453 0.7050
Stomach DNN1 0.6834 0.5406 0.6908DNN2 0.7015 0.5511 0.7078
Spleen DNN1 0.6852 0.5346 0.6961DNN2 0.6961 0.5563 0.7055
Table 4-III. Comparison of the two models’ AUC performance on GTEx data.
4.2.2.7 Mutations affect splice site choice
Single nucleotide polymorphisms (SNPs) occurring in splicing enhancers and silencers
could affect RBP binding affinity and result in differential intron selection. To
investigate the PDL model’s awareness of sequence changes and whether it could take
the SNP into consideration for prediction, we established an in silico mutagenesis
experiment as follows. We chose alternative splice sites from the Cystic Fibrosis
Conductance Regulator (CFTR) gene, mutations in which have been associated with
cystic fibrosis through dysregulation of splicing. Specifically, we selected 15 ‘bunches’
(30 introns, 2 introns per ‘bunch’), and mutated the nucleotides (one by one) in the
200 bp sequence centered on each splice site. We then measured how the changes in
sequence elements affected the PDL model’s prediction. Figures 4-9, 4-10, 4-11 show
the 3 splice sites in a ‘bunch’, namely the shared splice site and the two alternate
ones, at three individual loci (’bunches’). We observe that mutations within the
25 bp around the splice site could potentially affect alternative splicing. Also, the
mutations on the shared splice site, as opposed to the alternative splice site, have
a less pronounced effect, suggesting that it plays a smaller part in the alternative
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splicing outcome.
Figure 4-9. PDL predicts splicing ratio changes affected by point mutations. The top
sub-graph is the RNA sequence around the shared splice site, the bottom two sub-graphs
are the sequences of the other splice sites in the ‘bunch’. The sequences have 200
nucleotides, centered by the splice site. Colors represent the nucleotide to which the
wild-type nucleotide is mutated. The height of a nucleotide indicates the predicted splicing
ratio change which affected by this point mutation. Splice sites: chr7:117301030 (top),
chr7:117322058 (middle), chr7:117465747 (bottom).
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Figure 4-10. The point mutations on the shared splice site have a less pronounced effect.
Splice sites chr7:117542108 (top), chr7:117548641 (middle), 117559464 (bottom).
Figure 4-11. Mutations within the 25 bp around the splice site could potentially affect
alternative splicing. For this ‘bunch’, mutations in Exon regions brings more affection
to the splicing ratio change, compared to the intron regions. Splice site chr7:117714171
(top), introns: chr7:117710701 (middle), chr7:117712404 (bottom).
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4.3 Discussion
The mechanisms of alternative splicing as a gene regulatory process are still incom-
pletely understood. The splice site selection and the abundance of each splice variant
are determined by the combinatorial action of multiple regulatory factors, which act
in cis- or in trans to enhance or repress a particular outcome. Their signatures, and
the signatures of their interactions, are encoded in the sequence proximal to the splice
sites on the pre-mRNA molecule.
We described a probabilistic deep learning model (DPL model) to learn and reveal
how the interactions of cis-regulatory elements and trans-factors affect alternative
splicing, from the pre-mRNA sequence. The DPL model is trained on the reference
human genome sequences and splice junction read counts, extracted from spliced
RNA-seq read alignments generated by a ’splicing-aware’ aligner. This presents several
practical challenges. For instance, depending on the stringency of the alignment in
the presence in the reads of sequencing errors or other differences from the genome
reference, the aligner may report a number of false spliced alignments. Even when
the aligner uses existing gene annotations to inform the spliced-read placement, some
aligners will seek and force a false positive alignment that involves an annotated
exon boundary. Also, aligners may incorrectly place a read that matches to multiple
loci, altering the read counts. Prioritizing alignments in which read pairs map
concordantly may alleviate this problem, but only partly. In general, aligners have
different advantages and report spliced alignments leading to potential new and/or
different splice variants, either real or artifactual, according to different protocols. For
example, STAR produced substantially fewer spliced mappings when the alignment
was not guided by known splice sites [99]. A direct consequence to our model, when
aligners report numerous splices not corresponding to known introns, more effort
is required to construct a reliable set of introns for training from the novel splices.
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Moreover, to craft an accurate training and testing dataset for the DPL model, more
effort is needed to select alignment filters to fit the metrics and overall objectives of
the RNA-seq study. One particular challenge is the imbalanced data. For example, in
most cases where an alternative splicing event involves two or more introns sharing a
splice site, only one intron is highly expressed while the others have low expression
values and PSI ratios. Therefore, the data is biased towards introns with high and
low PSI ratios, resulting in higher performance of the models on these categories and
poorer performance in the cases when the intron is expressed at a moderate level.
Despite significant progress, the interplay between alternative splicing (AS) and
other RNA and DNA processes is poorly characterized. Recent evidence also indicates
that alternative splicing might be regulated not only by the concentrations of the
splicing factors or the relative concentrations of available splicing activators and
repressors, but also by a more complex process involving the transcription machinery.
In fact, transcription and pre-mRNA processing are not independent events. Rather,
they are highly coordinated in both time and space because splicing occurs in close
association with the transcript elongation by RNA polymerase II (Pol II). The 5’-
terminal exons can be switched through the use of alternative promoters and alternative
splicing. Similarly, the 3’-terminal exons can be switched by combining alternative
splicing with alternative polyadenylation sites [100].
Apart from the relationships that arise from the co-transcriptional splicing, DNA
methylation has more recently been reported to play a role in pre-mRNA splicing. As
evidence, human exons are more highly methylated than introns, and methylation
differences are stronger at the exon–intron boundaries [101].
Addressing these challenges requires integrative methods that combine data from
multiple technologies and convert them into biologically and clinically meaningful
insights. Particularly relevant, a deep neural network-based integration model learns a
joint representation of multiple datasets, preserving the structure of data and merging
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them during the analysis stage to generate diverse types of predictions. As two
examples, the program DeepCode was designed to predict splicing patterns and their
changes during hESC differentiation [102], and [103] propose a deep learning framework
to integrate RNA-seq and CLIP-seq data to analyze RBP-RNA interactions. As a
future research direction, we will investigate combining the PDL model with a deep
learning based methylation prediction module, to jointly measure the co-transcriptional
splicing.
To conclude, our sequence-based model is a first and important step in constructing
a deep learning based framework for alternative splicing regulatory and functional




In this thesis, we introduced several computational tools, aimed at quantitatively
measuring the splicing events, revealing the splicing regulation and understanding
the splicing process. Our methods leverage large scale RNA-seq data, reference RNA
sequences and RNA binding motifs. We first describe our contributions, then outline
limitations and possible extensions of the tools.
RNA-seq analyses aimed at determining differential splicing require a collection
of features, such as exons, introns, local events or full transcripts, based on which
to identify differences between two or more conditions. The accuracy of this set is
critical for the downstream quantification and differential analyses. These features are
extracted from a reference database, generated de novo by assembling the reads, or
simply enumerated from the input alignments where possible. Each of these methods
has drawbacks: reference features do not contain novel events, de novo ones may be
inaccurate and may miss low expression isoforms, and raw features contain artifacts.
So far there has been no judicious approach to selecting an optimal set of features. In
JULiP and JULiP2, we present two mathematically rigorous methods for selecting an
accurate set of introns that is as complete as possible. JULiP and JULiP2 extract
introns from large collections of RNA-seq data, directly from the spliced alignments,
and then refine them into a high-confidence set. JULiP and JULiP2 use similar
generalized linear models only with different read count models, based on the Poisson
and the negative binomial distributions, respectively. Additionally, an important
technical innovation of the tools is that they work by simultaneously modeling splice
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junction information across all samples, taking advantage of the latent information in
the set of samples to extract a highly accurate set of introns. Our evaluations showed
that JULiP and JULiP2 were superior methods for feature (intron) selection, being
able to reconstruct almost the entire set of features (90%) present in a collection of
RNA-seq samples and >10% more compared to assembly-based methods, with very
high precision. Additionally, JULiP2 builds on the selection step by incorporating a
statistical model for testing for differential splicing, including covariates from condition-
, sample- and gene-specific contributions. Overall, JULiP and JULiP2 are powerful
tools that can be used to select a nearly complete and highly accurate feature set for
downstream RNA-seq analyses to characterize splicing variation within and between
conditions.
Our second effort addresses a core problem in transcriptomics, namely identifying
differences in splicing between conditions. Currently, a variety of methods for differen-
tial splicing analysis are available, which differ in their selection of target features,
objective functions, and technical approaches, leading to poor consistency among the
results they produce. So far, there has been no tool that comprehensively addresses the
wide range of differential splicing patterns, and that allows for unbiased comparisons.
We designed MntJULiP to fill this gap and to computationally provide a comprehensive
view of alternative splicing variation. In MntJULiP, we implemented two Bayesian
models with two different objective functions: for determining the differences in intron
splicing abundance (DSA) and differences in intron splicing ratios (DSR) relative to
the local gene output, the two primary objective functions targeted by differential
splicing methods. MntJULiP represents splicing variation at intron level, inferring
introns directly from the alignments, thus capturing most splicing variations and
discovering new unannotated candidates while avoiding the pitfalls of assembly. A
unique capability of MntJULiP is its ability to perform multi-way comparisons, which
is desirable when characterizing complex time series or multi-condition experiments,
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to identify a global set of features that distinguish among subgroups or stages. To
complement our effort with designing differential splicing tools, and to meet the needs
for intuitive and easy to use visual representations, we developed a lightweight toolkit
Jutils. MntJULiP and Jutils collectively allow researchers to comprehensively survey
and characterize the complexity of splicing variation across collections of samples.
Additionally, JULiP, JULiP and MntJULiP are highly scalable and efficient tools,
and can process large collections comprising hundreds of RNA-seq data sets in a short
amount of time, typically <1 hour.
Lastly, it is important to understand the complexity of pre-mRNA splicing and how
changes in splice site choice come about. In recent years, a few machine learning based
methods were developed that take DNA sequences as input and apply general rules or
include results from state-of-the-art methods to predict splicing patterns [92, 93]. Such
rules or features may include the lengths of donor/acceptor exons, the lengths of introns,
motif scores, strength of donor/acceptor sites, whether exon can be translated without
stop codon, junction conservation scores in multiple species, and others. While these
early methods represent a modeling breakthrough, they are complicated, relying on
heterogeneous collections of previously curated motifs but without providing insights
into their role in the biological processes, and are designed for specific alternative
splicing patterns or events, such as exon skipping and alternative 3’/5’ site. To address
this challenge and provide a flexible model to analyze any types of alternative splicing
events, we developed a probabilistic deep learning method to predict alternative
splicing through deep modeling of cis-regulatory elements and trans-splicing factors.
Our model uses introns as the features, and therefore can capture a wide range of
alternative splicing patterns. It also achieves similar performance when trained solely
on the pre-mRNA sequences, without prior knowledge of regulatory motifs, which
means it can be applied effectively to other systems and species where such knowledge
is not available. Our PDL model can be trained rapidly with the aid of GPUs, thereby
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allowing it to have a large set of parameters and to deal with complex relationships
present in the data. It is our first and important attempt to computationally reveal
the tissue-regulated splicing code. Importantly, this DNN architecture can potentially
be extended to include heterogeneous data from different sources, to characterize the
cellular transcriptome and its variations along RNA processing pathways.
Overall, methods to characterize alternative splicing are structured around a set of
features, used to characterize splicing variation in a sample or condition, which they
quantify using read counts extracted from the alignment data, and then interrogate
with statistical tests to detect differences between conditions. Each step in this process,
including the selection of features, quantification and testing, is important to the
outcome of the analysis. Our work contributes in a significant way to all of these
computational problems. As an important design choice, our methods focus on introns
as the features used to represent alternative splicing. This choice avoids the pitfalls of
assembly, allows for the discovery of novel events, and captures most comprehensively
the variety of alternative splicing patterns. Introns are extracted directly from the
read alignments, thus ensuring the broadest collection of candidates, which is further
curated with the selection methods implemented in JULiP, JULiP2 and MntJULiP
before further analysis or modeling.
Nevertheless, some limitations, in particular related to the characteristics and
biases of the aligner and the ’mappability’ of the sequences, remain. For instance,
aligners may not be able to detect short exons, and shorter reads will be harder to
align across splice junctions and may result in underestimating the abundance or
even missing some low expression splice junctions entirely. Reads from repetitive
or duplicated regions may not be unambiguously aligned, as sequencing errors and
polymorphisms in the reads along with differences in the sequences of the genomic
loci may make it impossible to determine the true location. Further, alignment at
polymorphic loci may be biased against reads containing the non-reference allele.
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Methods that alleviate these biases, such as the use of a pangenome reference [104] or
accounting for read mappability [105] may be productive. Any further improvement
in the alignment software will directly contribute to improvements in our and others’
alternative splicing analysis tools.
Future extensions of these tools may target applicability to other sequencing
technologies, in particular long RNA sequencing reads. Short read RNA-seq, such as
Illumina RNA sequencing, has greatly expanded our ability to study the complexity
of transcriptomes, including the computational prediction of alternative splicing
events. However, short read RNA-seq reads have their shortages. Sufficient read
depth is necessary to cover the alternative exon-exon boundaries to allow detection,
which may hamper the identification of low expression isoforms and their unique
splicing variations. Further, short reads mapping to multiple isoforms would confound
alternative isoform identification and quantification. In contrast, long-read sequencing
technologies are making it possible to sequence single full-length transcripts. With
sufficient sequencing coverage, isoforms and the splice junctions can potentially be
reconstructed unambiguously. However, analysis of long-read sequences has it own
challenges, primarily the high error rates. To extend our tools to predict and analyze
alternative splicing variation using long reads, several changes must be made to adapt
to the inaccuracies in the sequencing data, while the statistical framework can be
more readily adapted. First, we will error correct the reads to increase the accuracy of
alignment [106]. Secondly, to correct for slight inaccuracies in the mapping of splice
junctions of the error corrected reads, we can jointly analyze alignments of the reads
along the genome, clustering candidate splice junctions within vicinities and selecting
representative splice sites, as implemented for instance in [107]. Multiple sequencing
runs per sample will produce sufficient reads to allow quantification and differential
analyses. Lastly, a benefit of long reads is that they can be more accurately aligned
to their correct location on the genome, thus improving the quantification. With
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these changes and other, we expect our JULiP family of tools to be able to accurately
predict and analyze alternative splicing events from long read RNA sequencing data.
Also, as future work on our modeling of alternative splicing in the larger context of
RNA processing pathways, we aim at designing an integrative machine learning frame-
work, which incorporates heterogeneous data -including sequences, motifs, epigenomic
data, tissue or condition labels, and expression data, examining the relationships
between the different components in the RNA processing pathways - DNA methylation,
RNA splicing and alternative splicing, and potentially RNA editing, and predicting
the effects of sequence variation. The rapid and widespread adoption of deep learning
in computational biology promises computational flexibility to effectively model and
integrate data given enough context and scale. Currently, identification of causality
and interaction in complex genotype-phenotype systems requires custom analyses
and domain expert interpretation. However, one might envision a future of data
accessibility, quality, and scale, that could enable near automated DL-based detection
of the genetic and epigenetic events and their phenotypic effects.
In conclusion, predicting alternative splicing of the pre-mRNA is a fundamental
and long standing problem in computational biology. Our work indicates that novel
machine learning algorithms, high performance hardware and large amounts of data,
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